| Code | Display | Japanese (ja) |
| LP29684-5 |
RAD |
放射線 |
| LP7839-6 |
PATH |
|
| LP7796-8 |
ENDO.GI |
内視鏡 |
| LP29693-6 |
Lab |
検体検査 |
| LP29708-2 |
Card |
|
| LP31759-1 |
DENTAL |
|
| LP7819-8 |
MICRO |
微生物検査 |
| 18725-2 |
Microbiology studies (set) |
|
| LP101394-7 |
adjusted for maternal weight |
|
| LP101907-6 |
corrected for age |
|
| LP115711-6 |
corrected for background |
|
| LP147359-6 |
adjusted for body weight |
|
| LP173482-3 |
1st specimen |
|
| LP173483-1 |
post cyanocobalamin |
|
| LP190769-2 |
adjusted for lean body mass+urine creatinine |
|
| LP20174-6 |
adjusted |
|
| LP20187-8 |
unadjusted |
|
| LP20440-1 |
corrected for nucleated erythrocytes |
|
| LP20441-9 |
hematocrit adjusted |
|
| LP20595-2 |
corrected for total protein |
|
| LP20603-4 |
adjusted to pH 7.4 |
|
| LP20606-7 |
saturation adjusted to 0.5 |
|
| LP20607-5 |
standard |
|
| LP20608-3 |
adjusted to patient's actual temperature |
|
| LP20617-4 |
adjusted for sex hormone binding globulin |
|
| LP208932-6 |
adjusted for age+sex+race+BMI |
|
| LP241992-9 |
adjusted for age |
|
| LP242679-1 |
adjusted for age+sex+race+ethnicity+educational attainment |
|
| LP29645-6 |
corrected for albumin |
|
| LP310257-3 |
standardized per IFCC-RMP for CDT |
|
| LP36655-6 |
adjusted for diabetes+weight |
|
| LP36656-4 |
adjusted for weight |
|
| LP36657-2 |
adjusted for diabetes |
|
| LP418256-6 |
corrected for glycerol |
|
| LP421238-9 |
corrected for ambient CO |
|
| LP426374-7 |
at end expiration+W sub-maximal exercise |
|
| LP426574-2 |
normalized |
|
| LP65567-7 |
adjusted for multiple gestations |
|
| LP66337-4 |
corrected for glucose |
|
| LP71889-7 |
adjusted for hemoglobin |
|
| LP71890-5 |
adjusted to body conditions |
|
| LP71891-3 |
uncorrected for compressible gas volume setting |
|
| LP71892-1 |
corrected for compressible gas volume |
|
| LP94499-8 |
uncorrected for compressible gas volume |
|
| LP97015-9 |
adjusted to specific gravity 1.024 |
|
| LP99753-3 |
corrected for heart rate |
|
| LP100005-0 |
post 6 mg dexamethasone PO overnight |
|
| LP100697-4 |
7 AM specimen |
|
| LP101161-0 |
2.75H post dose lactose PO |
|
| LP101162-8 |
2.25H post dose lactose PO |
|
| LP101163-6 |
1.75H post dose lactose PO |
|
| LP101164-4 |
1.25H post dose lactose PO |
|
| LP101880-5 |
during expiration |
|
| LP101881-3 |
during inspiration |
|
| LP101943-1 |
at end expiration |
|
| LP111141-0 |
Breath |
|
| LP111513-0 |
8th specimen post CFst |
|
| LP111514-8 |
9th specimen post CFst |
|
| LP111515-5 |
10th specimen post CFst |
|
| LP115673-8 |
end of expiration |
|
| LP121112-9 |
W methacholine inhaled |
|
| LP128681-6 |
afternoon specimen |
|
| LP129061-0 |
30M post maximum clot amplitude |
|
| LP129068-5 |
30M after maximum clot amplitude after addition of heparinase |
|
| LP129071-9 |
60M post maximum clot amplitude |
|
| LP133229-7 |
beginning of call |
|
| LP133232-1 |
end of call |
|
| LP133413-7 |
after addition of normal plasma 2H post incubation separate tubes |
|
| LP135214-7 |
patient arrival |
|
| LP135215-4 |
patient destination |
|
| LP135483-8 |
at delivery |
|
| LP135595-9 |
90M post exercise |
|
| LP135596-7 |
110M post exercise |
|
| LP135597-5 |
130M post exercise |
|
| LP135600-7 |
15M post exercise |
|
| LP135804-5 |
WO & W contrast |
|
| LP136078-5 |
developmental joint assessment |
|
| LP136176-7 |
20M post excision |
|
| LP136290-6 |
after maximum clot amplitude |
|
| LP136303-7 |
at dispatch |
|
| LP140231-4 |
premenopausal |
|
| LP140232-2 |
postmenopausal |
|
| LP140677-8 |
post 25 mg/mL methacholine |
|
| LP145288-9 |
12H post dose ifosfamide |
|
| LP145289-7 |
post dose ifosfamide |
|
| LP145290-5 |
7D post dose ifosfamide |
|
| LP145541-1 |
20M post dose lactose PO |
|
| LP145542-9 |
40M post dose lactose PO |
|
| LP145592-4 |
post dialysis/pre dialysis |
|
| LP150046-3 |
at peritoneal dialysis adequacy measurement |
|
| LP156504-5 |
PM trough specimen |
|
| LP156505-2 |
AM peak specimen |
|
| LP157148-0 |
pre contrast |
|
| LP157347-8 |
post dose HCG |
|
| LP157348-6 |
pre dose HCG |
|
| LP157517-6 |
W contrast IV+W air contrast PR |
|
| LP157794-1 |
post ejaculate |
|
| LP172879-1 |
pre dialysis-post dialysis |
|
| LP173487-2 |
2nd specimen/Streptococcus pneumoniae 12f Ab |
|
| LP173488-0 |
post amniocentesis |
|
| LP173490-6 |
pre amniocentesis |
|
| LP173492-2 |
2nd specimen/Streptococcus pneumoniae 14 Ab |
|
| LP173496-3 |
1H post 250 ug cortrosyn IM |
|
| LP173497-1 |
30M post 250 ug cortrosyn IM |
|
| LP173498-9 |
pre 250 ug cortrosyn IM |
|
| LP173502-8 |
post dose cyanocobalamin+intrinsic factor/Cobalamins |
|
| LP173511-9 |
after addition of protein C activator+Factor V depleted plasma/Coagulation surface induced |
|
| LP173512-7 |
after addition of protein C activator/Coagulation surface induced |
|
| LP173514-3 |
pre/post XXX challenge |
|
| LP173515-0 |
immediately after addition of normal plasma/Coagulation surface induced |
|
| LP173516-8 |
20M post incubation.37 deg c after addition of normal plasma |
|
| LP173518-4 |
hemodialysis |
|
| LP174429-3 |
20M post dose corticotropin |
|
| LP174563-9 |
post therapeutic diet |
|
| LP175701-4 |
post question response |
|
| LP182313-9 |
immediately after 1:1 addition of normal plasma |
|
| LP183687-5 |
usual |
|
| LP184287-3 |
pre delivery |
|
| LP185815-0 |
1.25 mg/ml |
|
| LP185816-8 |
1.25 ug/ml |
|
| LP185818-4 |
1.6 mmol/L |
|
| LP186034-7 |
at discharge |
|
| LP186079-2 |
2nd tube |
|
| LP186080-0 |
3rd tube |
|
| LP186081-8 |
4th tube |
|
| LP186950-4 |
in microenvironment |
|
| LP187034-6 |
during respiratory pause |
|
| LP188666-4 |
negative inspiratory force maneuver |
|
| LP189724-0 |
1st tube |
|
| LP189877-6 |
1M post dose indocyanine green |
|
| LP189878-4 |
15M post dose indocyanine green |
|
| LP190643-9 |
124H post XXX challenge |
|
| LP190740-3 |
WO & W contrast IV |
|
| LP190766-8 |
Dibucaine |
|
| LP192107-3 |
Indocyanine green |
|
| LP192129-7 |
dibucaine/Cholinesterase |
|
| LP199196-9 |
24H post incubation |
|
| LP199198-5 |
24H post XXX challenge |
|
| LP199669-5 |
6 umol/L |
|
| LP200132-1 |
2H dwell specimen |
|
| LP200133-9 |
4H dwell specimen |
|
| LP200203-0 |
used for drug calculation |
|
| LP200240-2 |
post XXX g sugar solution PO |
|
| LP200254-3 |
pre procedure |
|
| LP200255-0 |
post procedure |
|
| LP200319-4 |
after addition of factor X activated |
|
| LP200464-8 |
1.25H post dose arginine+insulin |
|
| LP200591-8 |
best corrected |
|
| LP200592-6 |
uncorrected |
|
| LP200597-5 |
dark-adapted |
|
| LP200598-3 |
light-adapted |
|
| LP200612-2 |
W cycloplegia |
|
| LP200613-0 |
WO cycloplegia |
|
| LP201231-0 |
at initial diagnosis |
|
| LP201232-8 |
at final disease stage |
|
| LP201627-9 |
W indocyanine green IV |
|
| LP201628-7 |
W fluorescein IV |
|
| LP20165-4 |
2nd specimen |
|
| LP20166-2 |
1st specimen |
|
| LP20167-0 |
pre 250 ug corticotropin IM |
|
| LP20168-8 |
30M post 250 ug corticotropin IM |
|
| LP20169-6 |
1H post 250 ug corticotropin IM |
|
| LP20171-2 |
10H post 1 mg dexamethasone PO overnight |
|
| LP20172-0 |
17H post 1 mg dexamethasone PO overnight |
|
| LP20173-8 |
24H post 1 mg dexamethasone PO overnight |
|
| LP20175-3 |
peak |
|
| LP20176-1 |
trough |
|
| LP20177-9 |
0.0% sodium chloride |
|
| LP20178-7 |
0.30% sodium chloride |
|
| LP20179-5 |
0.35% sodium chloride |
|
| LP20180-3 |
0.40% sodium chloride |
|
| LP20181-1 |
0.45% sodium chloride |
|
| LP20182-9 |
0.50% sodium chloride |
|
| LP20183-7 |
0.55% sodium chloride |
|
| LP20184-5 |
0.60% sodium chloride |
|
| LP20185-2 |
0.65% sodium chloride |
|
| LP20186-0 |
0.85% sodium chloride |
|
| LP20189-4 |
0.75% sodium chloride |
|
| LP20190-2 |
2H post peritoneal dialysis |
|
| LP20191-0 |
4H post peritoneal dialysis |
|
| LP20192-8 |
20M post dose TRH |
|
| LP20193-6 |
baseline |
|
| LP20194-4 |
1st specimen post XXX challenge |
|
| LP20196-9 |
1H post meal |
|
| LP20197-7 |
post 10H CFst |
|
| LP20198-5 |
post 12H CFst |
|
| LP20199-3 |
1H post 25 g xylose PO |
|
| LP20200-9 |
1H post dose xylose PO |
|
| LP20201-7 |
2H post 25 g xylose PO |
|
| LP20202-5 |
30M post 25 g xylose PO |
|
| LP20203-3 |
post 6H CFst |
|
| LP20204-1 |
post ejaculation |
|
| LP20205-8 |
post coitus |
|
| LP20206-6 |
15M post 50 g lactose PO |
|
| LP20207-4 |
7H post 75 g glucose PO |
|
| LP20208-2 |
3H post 25 g xylose PO |
|
| LP20209-0 |
4H post 25 g xylose PO |
|
| LP20210-8 |
5H post 25 g xylose PO |
|
| LP20213-2 |
2.5H post 75 g glucose PO |
|
| LP20214-0 |
3.5H post 75 g glucose PO |
|
| LP20215-7 |
4.5H post 75 g glucose PO |
|
| LP20216-5 |
45M post 50 g lactose PO |
|
| LP20217-3 |
45M post dose TRH IV |
|
| LP20218-1 |
post dialysis |
|
| LP20219-9 |
pre dialysis |
|
| LP20220-7 |
15M post 100 g glucose PO |
|
| LP20221-5 |
45M post 100 g glucose PO |
|
| LP20222-3 |
post immediate spin |
|
| LP20223-1 |
9H post 3 g metyraPONE PO overnight |
|
| LP20224-9 |
pre 3 g metyraPONE PO overnight |
|
| LP20225-6 |
8H post 30 mg/kg metyraPONE PO |
|
| LP20226-4 |
post 750 mg metyraPONE q4h X 6 |
|
| LP20228-0 |
1H post 1 ug/kg CRH IV |
|
| LP20229-8 |
1H post dose insulin IV |
|
| LP20230-6 |
1M post 1 ug/kg CRH IV |
|
| LP20231-4 |
30M post 1 ug/kg CRH IV |
|
| LP20232-2 |
30M post dose insulin IV |
|
| LP20233-0 |
45M post 1 ug/kg CRH IV |
|
| LP20234-8 |
45M post dose insulin IV |
|
| LP20235-5 |
5M post 1 ug/kg CRH IV |
|
| LP20236-3 |
pre 1 ug/kg CRH IV |
|
| LP20237-1 |
pre dose insulin IV |
|
| LP20238-9 |
post dose PO |
|
| LP20239-7 |
post 15000 U carotene QDx3 for 3D poly |
|
| LP20240-5 |
90s post 0.5 ug/kg pentagastrin IV |
|
| LP20241-3 |
10M post 2.4 mg/kg calcium short IV |
|
| LP20242-1 |
3H post 15 mg/kg calcium gluconate IV |
|
| LP20243-9 |
4H post 15 mg/kg calcium gluconate IV |
|
| LP20244-7 |
5M post 0.5 ug/kg pentagastrin IV |
|
| LP20245-4 |
5M post 2.4 mg/kg calcium short IV |
|
| LP20246-2 |
pre 0.5 ug/kg pentagastrin IV |
|
| LP20247-0 |
pre 2.4 mg/kg calcium short IV |
|
| LP20248-8 |
post calcium infusion |
|
| LP20249-6 |
1H post 300 ug cloNIDine PO |
|
| LP20250-4 |
2H post 300 ug cloNIDine PO |
|
| LP20251-2 |
3H post 300 ug cloNIDine PO |
|
| LP20252-0 |
pre 300 ug cloNIDine PO |
|
| LP20253-8 |
24H post 40 ug corticotropin IM BID 3 day |
|
| LP20254-6 |
48H post 40 ug corticotropin IM BID 3 day |
|
| LP20255-3 |
48H post 500 ug dexamethasone PO 2.5 day low dose q6h |
|
| LP20257-9 |
72H post 40 ug corticotropin IM BID 3 day |
|
| LP20258-7 |
pre 50 ug corticotropin IM 3 day |
|
| LP20259-5 |
pre 500 ug dexamethasone PO 2.5 day low dose q6h |
|
| LP20260-3 |
pre 2 mg dexamethasone PO 2.5 day high dose q6h |
|
| LP20262-9 |
1H post 0.05-0.15 U insulin/kg IV post 12H CFst |
|
| LP20263-7 |
1H post 250 ug corticotropin IM rapid |
|
| LP20264-5 |
1H post 250 ug corticotropin IV rapid |
|
| LP20266-0 |
24H post 2 mg dexamethasone PO 2.5 day high dose q6h |
|
| LP20267-8 |
24H post 500 ug corticotropin IM |
|
| LP20268-6 |
24H post 500 ug dexamethasone PO 2.5 day low dose q6h |
|
| LP20269-4 |
26H post 500 ug dexamethasone PO 2.5 day low dose q6h |
|
| LP20270-2 |
26H post 2 mg dexamethasone PO 2.5 day high dose q6h |
|
| LP20271-0 |
2D post 500 ug corticotropin IM |
|
| LP20272-8 |
30M post 0.05-0.15 U insulin/kg IV post 12H CFst |
|
| LP20273-6 |
30M post 250 ug corticotropin IM rapid |
|
| LP20274-4 |
30M post 250 ug corticotropin IV rapid |
|
| LP20275-1 |
32H post 40 ug corticotropin IM BID 3 day |
|
| LP20276-9 |
3D post 500 ug corticotropin IM |
|
| LP20277-7 |
48H post 2 mg dexamethasone PO 2.5 day high dose q6h |
|
| LP20279-3 |
50H post 500 ug dexamethasone PO 2.5 day low dose q6h |
|
| LP20280-1 |
50H post 2 mg dexamethasone PO 2.5 day high dose q6h |
|
| LP20281-9 |
56H post 40 ug corticotropin IM BID 3 day |
|
| LP20282-7 |
72H post 2 mg dexamethasone PO 2.5 day high dose q6h |
|
| LP20283-5 |
72H post 500 ug dexamethasone PO 2.5 day low dose q6h |
|
| LP20284-3 |
8H post 1 mg dexamethasone PO overnight |
|
| LP20285-0 |
8H post 2 mg dexamethasone PO 2.5 day high dose q6h |
|
| LP20286-8 |
8H post 500 ug dexamethasone PO 2.5 day low dose q6h |
|
| LP20287-6 |
8H post 40 ug corticotropin IM BID 3 day |
|
| LP20288-4 |
9.5H post 8 mg dexamethasone PO overnight high dose |
|
| LP20289-2 |
9H post 1 mg dexamethasone PO overnight |
|
| LP20290-0 |
9H post 8 mg dexamethasone PO overnight high dose |
|
| LP202916-5 |
overnight dwell |
|
| LP20291-8 |
pre 12H CFst |
|
| LP20292-6 |
pre 1 mg dexamethasone PO overnight |
|
| LP20293-4 |
pre 40 ug corticotropin IM 3 day |
|
| LP20294-2 |
pre 8 mg dexamethasone PO overnight high dose |
|
| LP20296-7 |
supine |
|
| LP20309-8 |
1.5H post 40 g galactose PO |
|
| LP20310-6 |
1H post 40 g galactose PO |
|
| LP20311-4 |
2H post 40 g galactose PO |
|
| LP20312-2 |
30M post 40 g galactose PO |
|
| LP20313-0 |
post 40 g dose PO |
|
| LP20314-8 |
10M post 0.2 U/kg secretin |
|
| LP20315-5 |
15M post 0.2 U/kg secretin |
|
| LP20316-3 |
20M post 0.2 U/kg secretin |
|
| LP20317-1 |
25M post 0.2 U/kg secretin |
|
| LP20318-9 |
30M post 0.2 U/kg secretin |
|
| LP20319-7 |
5M post 0.2 U/kg secretin |
|
| LP20320-5 |
pre 0.2 U/kg secretin |
|
| LP20321-3 |
30M post 100 g glucose PO |
|
| LP20322-1 |
1.5H post 0.5 g/kg glucose IV |
|
| LP20323-9 |
1.5H post 100 g glucose PO |
|
| LP20324-7 |
1.5H post 75 g glucose PO |
|
| LP20325-4 |
10M post 0.5 g/kg glucose IV |
|
| LP20326-2 |
1H post 0.5 g/kg glucose IV |
|
| LP20327-0 |
1H post 100 g glucose PO |
|
| LP20328-8 |
1H post 50 g glucose PO |
|
| LP20329-6 |
1H post 50 g lactose PO |
|
| LP20330-4 |
1H post 75 g glucose PO |
|
| LP20331-2 |
1M post 0.5 g/kg glucose IV |
|
| LP20332-0 |
20M post 0.5 g/kg glucose IV |
|
| LP20333-8 |
2H post 100 g glucose PO |
|
| LP20334-6 |
2H post 50 g lactose PO |
|
| LP20335-3 |
2H post 75 g glucose PO |
|
| LP20336-1 |
2H post meal |
|
| LP20337-9 |
30M post 0.5 g/kg glucose IV |
|
| LP20338-7 |
30M post 0.1 U/kg insulin |
|
| LP20339-5 |
30M post 50 g lactose PO |
|
| LP20340-3 |
30M post 75 g glucose PO |
|
| LP20341-1 |
3H post 100 g glucose PO |
|
| LP20342-9 |
3H post 75 g glucose PO |
|
| LP20343-7 |
3M post 0.5 g/kg glucose IV |
|
| LP20344-5 |
40M post 0.5 g/kg glucose IV |
|
| LP20345-2 |
4H post 100 g glucose PO |
|
| LP20346-0 |
4H post 75 g glucose PO |
|
| LP20347-8 |
5H post 100 g glucose PO |
|
| LP20348-6 |
5H post 75 g glucose PO |
|
| LP20349-4 |
5M post 0.5 g/kg glucose IV |
|
| LP20350-2 |
6H post 100 g glucose PO |
|
| LP20351-0 |
pre 0.5 g/kg glucose IV |
|
| LP20352-8 |
pre 100 g glucose PO |
|
| LP20353-6 |
pre 50 g lactose PO |
|
| LP20354-4 |
pre 75 g glucose PO |
|
| LP20355-1 |
post CFst |
|
| LP20356-9 |
1.5H post dose TOLBUTamide IV |
|
| LP20357-7 |
1H post dose TOLBUTamide IV |
|
| LP20358-5 |
2.5H post dose TOLBUTamide IV |
|
| LP20359-3 |
2H post dose TOLBUTamide IV |
|
| LP20360-1 |
30M post dose TOLBUTamide IV |
|
| LP20361-9 |
3H post dose TOLBUTamide IV |
|
| LP203623-6 |
Dwell |
|
| LP20362-7 |
pre dose TOLBUTamide IV |
|
| LP20363-5 |
post EDTA therapy |
|
| LP20365-0 |
105M post 100 g lutropin IV |
|
| LP20366-8 |
15M post 100 g lutropin IV |
|
| LP20367-6 |
1H post 100 g lutropin IV |
|
| LP20368-4 |
1H post dose gonadotropin releasing hormone |
|
| LP20369-2 |
2H post 100 g lutropin IV |
|
| LP20370-0 |
2H post dose gonadotropin releasing hormone |
|
| LP20371-8 |
30M post 100 g lutropin IV |
|
| LP20372-6 |
30M post dose gonadotropin releasing hormone |
|
| LP20373-4 |
45M post 100 g lutropin IV |
|
| LP20374-2 |
75M post 100 g lutropin IV |
|
| LP20375-9 |
pre dose gonadotropin releasing hormone |
|
| LP20376-7 |
10M post standing |
|
| LP20377-5 |
post 12H FFst |
|
| LP20378-3 |
post 8H FFst |
|
| LP20379-1 |
1H post dose L-dopa PO |
|
| LP20380-9 |
1H post dose TRH IV |
|
| LP20381-7 |
2H post dose L-dopa PO |
|
| LP20382-5 |
30M post dose TRH IV |
|
| LP20383-3 |
3H post dose L-dopa PO |
|
| LP20384-1 |
pre dose L-dopa PO |
|
| LP20385-8 |
pre dose TRH IV |
|
| LP20386-6 |
5H post 600 ug furosemide PO |
|
| LP20387-4 |
pre 600 ug furosemide PO |
|
| LP20388-2 |
3H post 5000 units |
|
| LP20389-0 |
6H post 5000 units |
|
| LP20390-8 |
pre 5000 units |
|
| LP20391-6 |
1H post 1 g/kg glucose PO |
|
| LP20392-4 |
2H post 1 g/kg glucose PO |
|
| LP20393-2 |
3H post 1 g/kg glucose PO |
|
| LP20394-0 |
52H post 250 ug L-dopa TID 2day PO |
|
| LP20395-7 |
pre 1 g/kg glucose PO |
|
| LP20396-5 |
pre 250 ug L-dopa TID 2day PO |
|
| LP20397-3 |
96H post 5000 U HCG IM |
|
| LP20398-1 |
pre 5000 U HCG IM |
|
| LP20400-5 |
3D post 25 TU ID |
|
| LP20401-3 |
3D post 5 TU ID |
|
| LP20402-1 |
upright |
|
| LP20403-9 |
post 50 g glucose PO |
|
| LP20405-4 |
random |
|
| LP20406-2 |
trough >12h post dose |
|
| LP20407-0 |
12H post dose |
|
| LP20408-8 |
24H post dose |
|
| LP20409-6 |
>6h post dose |
|
| LP20410-4 |
>12h post dose |
|
| LP20411-2 |
>45m post bolus dose |
|
| LP20412-0 |
1-2W post dose |
|
| LP20413-8 |
48H post dose |
|
| LP20414-6 |
72H post dose |
|
| LP20417-9 |
3D post 50 ug Candida albicans ID |
|
| LP20418-7 |
3D post 0.1 mL mumps ID |
|
| LP20419-5 |
3D post 50 ug trichophyton ID |
|
| LP20420-3 |
immediately after addition of normal plasma |
|
| LP20422-9 |
20M post venistasis |
|
| LP20423-7 |
10M post venistasis |
|
| LP20426-0 |
6H post 75 g glucose PO |
|
| LP20428-6 |
2.5H post 100 g glucose PO |
|
| LP20429-4 |
3.5H post 100 g glucose PO |
|
| LP20430-2 |
4.5H post 100 g glucose PO |
|
| LP20431-0 |
5.5H post 100 g glucose PO |
|
| LP20432-8 |
6H post 500 mg bentiromide PO |
|
| LP20433-6 |
2H post 250 ug corticotropin IM |
|
| LP20434-4 |
45M post 250 ug corticotropin IM |
|
| LP20435-1 |
1.5H post 250 ug corticotropin IM |
|
| LP20436-9 |
evening specimen |
|
| LP20437-7 |
morning specimen |
|
| LP20438-5 |
12H post peritoneal dialysis |
|
| LP20442-7 |
post vasectomy |
|
| LP20443-5 |
1H post XXX challenge |
|
| LP20444-3 |
2H post XXX challenge |
|
| LP20445-0 |
3H post XXX challenge |
|
| LP20446-8 |
2nd specimen post XXX challenge |
|
| LP20447-6 |
3rd specimen post XXX challenge |
|
| LP20448-4 |
4th specimen post XXX challenge |
|
| LP20449-2 |
5th specimen post XXX challenge |
|
| LP20450-0 |
6th specimen post XXX challenge |
|
| LP20451-8 |
7th specimen post XXX challenge |
|
| LP20452-6 |
8th specimen post XXX challenge |
|
| LP20453-4 |
4th specimen |
|
| LP20454-2 |
5th specimen |
|
| LP20455-9 |
4H post XXX challenge |
|
| LP20456-7 |
9th specimen post XXX challenge |
|
| LP20457-5 |
10th specimen post XXX challenge |
|
| LP20458-3 |
30M post XXX challenge |
|
| LP20459-1 |
20M post XXX challenge |
|
| LP20460-9 |
2.5H post XXX challenge |
|
| LP20461-7 |
post XXX challenge |
|
| LP20462-5 |
2H specimen |
|
| LP20463-3 |
4H specimen |
|
| LP20464-1 |
24H specimen |
|
| LP20465-8 |
3rd specimen |
|
| LP20466-6 |
6th specimen |
|
| LP20467-4 |
7th specimen |
|
| LP20468-2 |
8th specimen |
|
| LP20470-8 |
7H post meal |
|
| LP20471-6 |
11th specimen post XXX challenge |
|
| LP20472-4 |
12th specimen post XXX challenge |
|
| LP20473-2 |
13th specimen post XXX challenge |
|
| LP20474-0 |
14th specimen post XXX challenge |
|
| LP20475-7 |
15th specimen post XXX challenge |
|
| LP20477-3 |
15M post XXX challenge |
|
| LP20478-1 |
6.5H post XXX challenge |
|
| LP20479-9 |
7H post XXX challenge |
|
| LP20480-7 |
7.5H post XXX challenge |
|
| LP20481-5 |
8H post XXX challenge |
|
| LP20482-3 |
9H post XXX challenge |
|
| LP20483-1 |
10H post XXX challenge |
|
| LP20484-9 |
12H post XXX challenge |
|
| LP20485-6 |
15M post dose lactose PO |
|
| LP20486-4 |
6th specimen post dose lactose |
|
| LP20487-2 |
3.5H post dose lactose PO |
|
| LP20488-0 |
10M pre XXX challenge |
|
| LP20489-8 |
2M post XXX challenge |
|
| LP20490-6 |
8M post XXX challenge |
|
| LP20491-4 |
10M post XXX challenge |
|
| LP20492-2 |
4M post XXX challenge |
|
| LP20493-0 |
40M post XXX challenge |
|
| LP20494-8 |
50M post XXX challenge |
|
| LP20495-5 |
70M post XXX challenge |
|
| LP20496-3 |
15M pre XXX challenge |
|
| LP20498-9 |
pre XXX challenge |
|
| LP20499-7 |
45M post XXX challenge |
|
| LP20500-2 |
3.5H post XXX challenge |
|
| LP20501-0 |
4.5H post XXX challenge |
|
| LP20502-8 |
5.5H post XXX challenge |
|
| LP20503-6 |
11H post XXX challenge |
|
| LP20505-1 |
19M post XXX challenge |
|
| LP20506-9 |
22M post XXX challenge |
|
| LP20507-7 |
1.5H post XXX challenge |
|
| LP20509-3 |
70M specimen |
|
| LP20510-1 |
5H post XXX challenge |
|
| LP20511-9 |
6H post XXX challenge |
|
| LP20517-6 |
15M post 250 ug corticotropin |
|
| LP20518-4 |
1H post 250 ug corticotropin |
|
| LP20519-2 |
30M post 250 ug corticotropin |
|
| LP20520-0 |
3H post 50 g lactose PO |
|
| LP20521-8 |
4H post 50 g lactose PO |
|
| LP20523-4 |
1H post 25 mg captopril PO |
|
| LP20524-2 |
2H post 25 mg captopril PO |
|
| LP20525-9 |
10M post 1 mg glucagon IV |
|
| LP20526-7 |
15M post 1 mg glucagon IV |
|
| LP20527-5 |
5M post 1 mg glucagon IV |
|
| LP20529-1 |
2.5H post 50 g lactose PO |
|
| LP20530-9 |
5H post 50 g lactose PO |
|
| LP20531-7 |
1.5H post dose TRH IV |
|
| LP20532-5 |
15M post dose TRH IV |
|
| LP20533-3 |
2H post dose TRH IV |
|
| LP20534-1 |
5.5H post 75 g glucose PO |
|
| LP20537-4 |
2M post 0.2 U/kg secretin |
|
| LP20538-2 |
1.5H post 50 g lactose PO |
|
| LP20548-1 |
immediately after 1:4 addition of normal plasma |
|
| LP20555-6 |
post dose |
|
| LP20556-4 |
1.5M post XXX challenge |
|
| LP20557-2 |
5M post XXX challenge |
|
| LP20558-0 |
1M post XXX challenge |
|
| LP20560-6 |
80M post XXX challenge |
|
| LP20561-4 |
105M post XXX challenge |
|
| LP20562-2 |
25M post XXX challenge |
|
| LP20563-0 |
post meal |
|
| LP20571-3 |
post dose glucose |
|
| LP20573-9 |
75M post XXX challenge |
|
| LP20574-7 |
standing |
|
| LP20575-4 |
3H post dose |
|
| LP20576-2 |
6H post dose |
|
| LP20577-0 |
52H post XXX challenge |
|
| LP20578-8 |
30M post collection |
|
| LP20587-9 |
4D post XXX challenge |
|
| LP20588-7 |
post dose TRH |
|
| LP20589-5 |
post 8H CFst |
|
| LP20597-8 |
post partum |
|
| LP20599-4 |
pre partum |
|
| LP20601-8 |
6H post 50 g lactose PO |
|
| LP20602-6 |
12H post 50 g lactose PO |
|
| LP20609-1 |
2H post dose glucose |
|
| LP20610-9 |
3H post dose glucose |
|
| LP20611-7 |
1H post dose glucose |
|
| LP20612-5 |
30M post dose glucose |
|
| LP20614-1 |
post 50 g glucose |
|
| LP20615-8 |
1H post dose corticotropin |
|
| LP20619-0 |
11 PM specimen |
|
| LP20620-8 |
1H post ejaculation |
|
| LP20621-6 |
2H post ejaculation |
|
| LP20622-4 |
3H post ejaculation |
|
| LP20624-0 |
40M post 0.2 U/kg secretin |
|
| LP20625-7 |
45M post 0.2 U/kg secretin |
|
| LP20626-5 |
2.5H post 0.2 U/kg secretin |
|
| LP20627-3 |
3H post 0.2 U/kg secretin |
|
| LP20628-1 |
3.5H post 0.2 U/kg secretin |
|
| LP20629-9 |
4H post 0.2 U/kg secretin |
|
| LP20630-7 |
50M post 0.2 U/kg secretin |
|
| LP20631-5 |
7M post 0.2 U/kg secretin |
|
| LP20632-3 |
1H post 0.2 U/kg secretin |
|
| LP20633-1 |
1.5H post 0.2 U/kg secretin |
|
| LP20634-9 |
2H post 0.2 U/kg secretin |
|
| LP20635-6 |
1M post 0.5 ug/kg pentagastrin IV |
|
| LP20636-4 |
3M post 0.5 ug/kg pentagastrin IV |
|
| LP20637-2 |
10M post 0.5 ug/kg pentagastrin IV |
|
| LP20638-0 |
2M post 0.5 ug/kg pentagastrin IV |
|
| LP20639-8 |
15M post dose gonadotropin releasing hormone |
|
| LP20640-6 |
45M post dose gonadotropin releasing hormone |
|
| LP20643-0 |
4H post ejaculation |
|
| LP20644-8 |
1H post 5 g xylose PO |
|
| LP20645-5 |
2H post 5 g xylose PO |
|
| LP20646-3 |
2H post dose xylose PO |
|
| LP20647-1 |
post 25 g xylose PO |
|
| LP20648-9 |
post 5 g xylose PO |
|
| LP20649-7 |
post dose xylose PO |
|
| LP20650-5 |
2D post 0.1 mL brucellin ID |
|
| LP20651-3 |
3D post 0.1 mL brucellin ID |
|
| LP20652-1 |
1D post 0.1 mL mallein ID |
|
| LP20653-9 |
2D post 0.1 mL mallein ID |
|
| LP20654-7 |
1D post dose ID |
|
| LP20655-4 |
2D post dose ID |
|
| LP20656-2 |
3D post dose ID |
|
| LP20657-0 |
3D post 0.1 mL leishmanin ID |
|
| LP20658-8 |
3D post 0.1 mL avian tuberculin ID |
|
| LP20659-6 |
3D post 0.1 mL johnin ID |
|
| LP20660-4 |
post 0.1 mL tricin ID |
|
| LP20661-2 |
2D post dose mammalian tuberculin ID |
|
| LP20662-0 |
3D post dose avian tuberculin ID |
|
| LP20663-8 |
3D post dose mammalian tuberculin ID |
|
| LP207806-3 |
preoperative |
|
| LP207893-1 |
post preoperative therapy |
|
| LP207954-1 |
postoperative |
|
| LP20815-4 |
5.5H post dose glucose |
|
| LP20816-2 |
15M post dose glucose |
|
| LP20819-6 |
1H post 100 ug luteinizing releasing hormone IV |
|
| LP20820-4 |
30M post 100 ug luteinizing releasing hormone IV |
|
| LP20821-2 |
1.5H post 100 ug luteinizing releasing hormone IV |
|
| LP20822-0 |
2H post 100 ug luteinizing releasing hormone IV |
|
| LP20824-6 |
pre 50 g glucose PO |
|
| LP20825-3 |
5H post 500 mg calcium PO |
|
| LP20828-7 |
10M post 200 ug TRH IV |
|
| LP20829-5 |
1H post 200 ug TRH IV |
|
| LP20830-3 |
20M post 200 ug TRH IV |
|
| LP20831-1 |
2H post 200 ug TRH IV |
|
| LP20832-9 |
30M post 200 ug TRH IV |
|
| LP20833-7 |
40M post 200 ug TRH IV |
|
| LP20834-5 |
50M post 200 ug TRH IV |
|
| LP20849-3 |
1.5H post dose xylose PO |
|
| LP208591-0 |
post mitogen stimulation |
|
| LP20861-8 |
1st specimen post exercise |
|
| LP20862-6 |
2nd specimen post exercise |
|
| LP20863-4 |
3rd specimen post exercise |
|
| LP20864-2 |
4th specimen post exercise |
|
| LP20865-9 |
5th specimen post exercise |
|
| LP20866-7 |
6th specimen post exercise |
|
| LP20867-5 |
pre exercise |
|
| LP20868-3 |
pre 500 mg calcium PO |
|
| LP20870-9 |
pre dose TRH IN |
|
| LP20871-7 |
30M post dose TRH IN |
|
| LP20872-5 |
1D post XXX challenge |
|
| LP20873-3 |
2D post XXX challenge |
|
| LP20890-7 |
post pyridoxine PO |
|
| LP20891-5 |
post 250 mg pyridoxine PO |
|
| LP20892-3 |
pre 250 mg pyridoxine PO |
|
| LP209057-1 |
W single state of exercise |
|
| LP209060-5 |
W multiple states of exercise |
|
| LP20921-0 |
24H post dose corticotropin |
|
| LP20922-8 |
8H post dose corticotropin |
|
| LP20923-6 |
30M post dose corticotropin |
|
| LP20925-1 |
48H post dose corticotropin |
|
| LP20926-9 |
72H post dose corticotropin |
|
| LP20928-5 |
32H post dose corticotropin |
|
| LP20930-1 |
56H post dose corticotropin |
|
| LP20931-9 |
4H post dose glucose |
|
| LP20932-7 |
5H post dose glucose |
|
| LP20933-5 |
6H post dose glucose |
|
| LP20934-3 |
1.5H post dose glucose |
|
| LP20935-0 |
2.5H post dose glucose |
|
| LP20936-8 |
3.5H post dose glucose |
|
| LP20937-6 |
4.5H post dose glucose |
|
| LP20938-4 |
45M post dose glucose |
|
| LP21153-9 |
4H post dose lactose PO |
|
| LP21154-7 |
5H post dose lactose PO |
|
| LP21174-5 |
22nd specimen post XXX challenge |
|
| LP21175-2 |
18th specimen post XXX challenge |
|
| LP21176-0 |
24H post ejaculation |
|
| LP21177-8 |
12H post ejaculation |
|
| LP21180-2 |
16th specimen post XXX challenge |
|
| LP21181-0 |
17th specimen post XXX challenge |
|
| LP21182-8 |
19th specimen post XXX challenge |
|
| LP21183-6 |
20th specimen post XXX challenge |
|
| LP21184-4 |
21st specimen post XXX challenge |
|
| LP21185-1 |
23rd specimen post XXX challenge |
|
| LP21187-7 |
24th specimen post XXX challenge |
|
| LP21188-5 |
25th specimen post XXX challenge |
|
| LP212272-1 |
W contrast retrograde |
|
| LP213623-4 |
Mitogen |
|
| LP213625-9 |
18F-NaF |
|
| LP213626-7 |
Florbetapir |
|
| LP213627-5 |
Ra-223 |
|
| LP221198-7 |
W standing |
|
| LP230193-7 |
at rest |
|
| LP231610-9 |
pre symptom onset |
|
| LP231624-0 |
pre 18Yo |
|
| LP231627-3 |
8 weeks pre symptom onset or diagnosis |
|
| LP231800-6 |
W 18F-FDG IV |
|
| LP231997-0 |
post dose follitropin |
|
| LP231998-8 |
post dose gonadotropin releasing hormone |
|
| LP232000-2 |
post dose lutropin |
|
| LP232046-5 |
eyes open+on solid surface |
|
| LP232049-9 |
eyes closed+on solid surface |
|
| LP232052-3 |
eyes open+on foam surface |
|
| LP232055-6 |
eyes closed+on foam surface |
|
| LP232058-0 |
eyes open+tandem stance+on solid surface |
|
| LP234189-1 |
18F-FDG |
|
| LP242680-9 |
2M post trial start |
|
| LP242694-0 |
Follitropin |
|
| LP247778-6 |
at onset of illness |
|
| LP247779-4 |
at cessation of pregnancy |
|
| LP248244-8 |
at admission |
|
| LP248531-8 |
week 1 |
|
| LP248532-6 |
week 2 |
|
| LP249020-1 |
60M after maximum clot amplitude after addition of heparinase |
|
| LP249275-1 |
750 ug/mL |
|
| LP253535-1 |
at intake |
|
| LP253537-7 |
at exit |
|
| LP253561-7 |
unladen |
|
| LP262702-6 |
1st trimester |
|
| LP262703-4 |
2nd trimester |
|
| LP264291-8 |
W exercise |
|
| LP265578-7 |
50M post dose fructose PO |
|
| LP265579-5 |
40M post dose fructose PO |
|
| LP265580-3 |
20M post dose fructose PO |
|
| LP265581-1 |
10M post dose fructose PO |
|
| LP265582-9 |
10M post dose lactose PO |
|
| LP265585-2 |
50M post dose lactose PO |
|
| LP266032-4 |
during pregnancy |
|
| LP266061-3 |
W Chemotherapy |
|
| LP266097-7 |
during apnea |
|
| LP266100-9 |
W pain |
|
| LP266103-3 |
lying in L-lateral position |
|
| LP266328-6 |
during anesthesia |
|
| LP266544-8 |
500 Hz |
|
| LP266545-5 |
1000 Hz |
|
| LP266546-3 |
2000 Hz |
|
| LP266547-1 |
3000 Hz |
|
| LP266548-9 |
4000 Hz |
|
| LP266549-7 |
6000 Hz |
|
| LP266550-5 |
8000 Hz |
|
| LP266628-9 |
W embolic agent IA |
|
| LP266708-9 |
W intraarterial hepatic injection |
|
| LP267360-8 |
pre enrollment in ADAPTABLE study |
|
| LP267361-6 |
post enrollment in ADAPTABLE study |
|
| LP267363-2 |
during hospitalization |
|
| LP269268-1 |
6H post dose levothyroxine |
|
| LP269269-9 |
4H post dose levothyroxine |
|
| LP269270-7 |
3H post dose levothyroxine |
|
| LP269271-5 |
2H post dose levothyroxine |
|
| LP269272-3 |
1H post dose levothyroxine |
|
| LP270304-1 |
Levothyroxine |
|
| LP270822-2 |
250 Hz |
|
| LP270823-0 |
750 Hz |
|
| LP270824-8 |
1500 Hz |
|
| LP270826-3 |
5000 Hz |
|
| LP281858-3 |
W contrast IV && Multisection |
|
| LP281862-5 |
W flexion + W extension) |
|
| LP281867-4 |
W standing) |
|
| LP281869-0 |
W stress & W radionuclide IV |
|
| LP281871-6 |
WO contrast && Multisection |
|
| LP29303-2 |
peak post extended interval dosing |
|
| LP29304-0 |
trough post extended interval dosing |
|
| LP29305-7 |
random post extended interval dosing |
|
| LP29307-3 |
1H post incubation after addition of normal plasma |
|
| LP29308-1 |
1H post incubation |
|
| LP29319-8 |
2D post 0.1 mL coccidioidin ID |
|
| LP29322-2 |
4 PM specimen |
|
| LP29328-9 |
105M post 100 ug luteinizing releasing hormone IV |
|
| LP29329-7 |
15M post 100 ug luteinizing releasing hormone IV |
|
| LP29330-5 |
45M post 100 ug luteinizing releasing hormone IV |
|
| LP29332-1 |
75M post 100 ug luteinizing releasing hormone IV |
|
| LP29338-8 |
1M pre XXX challenge |
|
| LP29339-6 |
30M pre XXX challenge |
|
| LP29341-2 |
1.5H post dose insulin IV |
|
| LP29342-0 |
1.6H post dose glucose |
|
| LP29343-8 |
10 AM specimen |
|
| LP29344-6 |
11 AM specimen |
|
| LP29345-3 |
1H post 1.2 g/kg lactose PO |
|
| LP29346-1 |
2 PM specimen |
|
| LP29347-9 |
2.3H post dose glucose |
|
| LP29348-7 |
2.6H post dose glucose |
|
| LP29349-5 |
20M post dose glucose |
|
| LP29350-3 |
2H post 1.2 g/kg lactose PO |
|
| LP29351-1 |
3H post 1.2 g/kg lactose PO |
|
| LP29353-7 |
3.3H post dose glucose |
|
| LP29354-5 |
3.6H post dose glucose |
|
| LP29355-2 |
40M post dose glucose |
|
| LP29360-2 |
6H post dose methionine |
|
| LP29361-0 |
1.3H post XXX challenge |
|
| LP29362-8 |
1.6H post XXX challenge |
|
| LP29363-6 |
2.3H post XXX challenge |
|
| LP29364-4 |
2.6H post XXX challenge |
|
| LP29365-1 |
3.3H post XXX challenge |
|
| LP29366-9 |
3.6H post XXX challenge |
|
| LP29370-1 |
post void |
|
| LP29376-8 |
1H post dose U/kg insulin IV |
|
| LP29377-6 |
30M post dose U/kg insulin IV |
|
| LP29378-4 |
1.5H post 0.05-0.15 U insulin/kg IV post 12H CFst |
|
| LP29380-0 |
1.5H post 100 g lutropin IV |
|
| LP29381-8 |
1.5H post dose gonadotropin releasing hormone |
|
| LP29382-6 |
3 PM specimen |
|
| LP29383-4 |
5 PM specimen |
|
| LP29451-9 |
6H post ejaculation |
|
| LP29454-3 |
0.60% sodium chloride 24H 37 deg C incubation |
|
| LP29455-0 |
0.65% sodium chloride 24H 37 deg C incubation |
|
| LP29456-8 |
0.75% sodium chloride 24H 37 deg C incubation |
|
| LP29554-0 |
2.5H post dose xylose PO |
|
| LP29556-5 |
post dose urea |
|
| LP29557-3 |
2D post 0.1 mL Candida albicans ID |
|
| LP29558-1 |
2D post 0.1 mL histoplasmin ID |
|
| LP29559-9 |
2D post 0.1 mL mumps ID |
|
| LP29560-7 |
2D post 0.1ml trichophyton ID |
|
| LP29561-5 |
1.3H post dose glucose |
|
| LP29584-7 |
post dose cyanocobalamin |
|
| LP29586-2 |
post dose cyanocobalamin+intrinsic factor |
|
| LP29587-0 |
0.0% sodium chloride 24H 37 deg C incubation |
|
| LP29588-8 |
0.85% sodium chloride 24H 37 deg C incubation |
|
| LP29589-6 |
0.55% sodium chloride 24H 37 deg C incubation |
|
| LP29590-4 |
0.50% sodium chloride 24H 37 deg C incubation |
|
| LP29591-2 |
0.45% sodium chloride 24H 37 deg C incubation |
|
| LP29592-0 |
0.40% sodium chloride 24H 37 deg C incubation |
|
| LP29593-8 |
0.35% sodium chloride 24H 37 deg C incubation |
|
| LP29594-6 |
0.30% sodium chloride 24H 37 deg C incubation |
|
| LP29596-1 |
20M post incubation after addition of normal plasma |
|
| LP29600-1 |
lying |
|
| LP30662-8 |
1D post 50 ug Candida albicans ID |
|
| LP30663-6 |
2D post 50 ug Candida albicans ID |
|
| LP30664-4 |
1D post 0.1 mL mumps ID |
|
| LP30665-1 |
2D post 50 ug trichophyton ID |
|
| LP30666-9 |
1D post 50 ug trichophyton ID |
|
| LP30667-7 |
1D post dose mammalian tuberculin ID |
|
| LP30766-7 |
45M post dose lactose PO |
|
| LP30784-0 |
fresh |
|
| LP30785-7 |
Incubated |
|
| LP30795-6 |
30M post 1.2 g/kg lactose PO |
|
| LP30852-5 |
2H post dose lactose PO |
|
| LP30853-3 |
2.5H post dose lactose PO |
|
| LP30854-1 |
3H post dose lactose PO |
|
| LP30856-6 |
pre dose lactose PO |
|
| LP30857-4 |
30M post dose lactose PO |
|
| LP30858-2 |
1H post dose lactose PO |
|
| LP30859-0 |
1.5H post dose lactose PO |
|
| LP30871-5 |
High dose |
|
| LP30872-3 |
Low dose |
|
| LP30879-8 |
1500 ug/mL |
|
| LP30880-6 |
1200 ug/mL |
|
| LP30881-4 |
900 ug/mL |
|
| LP30882-2 |
600 ug/mL |
|
| LP30883-0 |
300 ug/mL |
|
| LP30921-8 |
immediately after addition of protamine sulfate |
|
| LP309958-9 |
5M pre 1 ug/kg CRH IV |
|
| LP309959-7 |
1M pre 1 ug/kg CRH IV |
|
| LP309960-5 |
2M post 1 ug/kg CRH IV |
|
| LP309961-3 |
10M post 1 ug/kg CRH IV |
|
| LP310239-1 |
post birth |
|
| LP31506-6 |
pre dose radioactive cyanocobalamin |
|
| LP31581-9 |
2H post dose |
|
| LP31582-7 |
6H post dose methionine - post CFst |
|
| LP31583-5 |
30M post dose TRH |
|
| LP31584-3 |
1H post dose TRH |
|
| LP31585-0 |
1.5H post dose TRH |
|
| LP31586-8 |
2H post dose TRH |
|
| LP31587-6 |
pre dose TRH |
|
| LP31593-4 |
2H post incubation after addition of normal plasma |
|
| LP31597-5 |
15M post incubation |
|
| LP31599-1 |
1H post incubation after 1:4 addition of normal plasma |
|
| LP31600-7 |
2H post incubation after 1:4 addition of normal plasma |
|
| LP31604-9 |
30M post incubation |
|
| LP31605-6 |
2H post incubation |
|
| LP31612-2 |
1.5H post 200 ug TRH IV |
|
| LP31751-8 |
15M post 250 ug corticotropin IM |
|
| LP31752-6 |
10M post dose glucose |
|
| LP31761-7 |
pre or post dose TRH |
|
| LP31762-5 |
pre or post XXX challenge |
|
| LP31763-3 |
pre or post dose arginine |
|
| LP31764-1 |
pre or post dose cloNIDine |
|
| LP31765-8 |
pre or post dose glucagon |
|
| LP31766-6 |
pre or post dose glucose |
|
| LP31767-4 |
pre or post dose insulin |
|
| LP31768-2 |
pre or post dose corticotropin |
|
| LP31784-9 |
30M post incubation after addition of normal plasma |
|
| LP31942-3 |
immediately after 1:2 addition of normal plasma |
|
| LP32460-5 |
1st specimen/2nd specimen |
|
| LP32462-1 |
2nd specimen/1st specimen |
|
| LP32529-7 |
Corticotropin |
|
| LP32530-5 |
Dexamethasone |
|
| LP32532-1 |
Xylose |
|
| LP32533-9 |
Lactose |
|
| LP32534-7 |
Glucose |
|
| LP32542-0 |
insulin |
|
| LP32547-9 |
Calcium |
|
| LP32548-7 |
cloNIDine |
|
| LP32549-5 |
Cyanocobalamin |
|
| LP32557-8 |
Gonadotropin releasing hormone |
|
| LP32562-8 |
Glucagon |
|
| LP32568-5 |
Pyridoxine |
|
| LP32571-9 |
Methionine |
|
| LP32575-0 |
Arginine |
|
| LP32576-8 |
Bentiromide |
|
| LP32624-6 |
Candida albicans |
|
| LP32625-3 |
Tuberculin |
|
| LP32628-7 |
Trichophyton |
|
| LP32647-7 |
Urea |
|
| LP32689-9 |
Captopril |
|
| LP32690-7 |
Carotene |
|
| LP32693-1 |
Furosemide |
|
| LP32694-9 |
Galactose |
|
| LP32697-2 |
Luteinizing releasing hormone |
|
| LP32698-0 |
Lutropin |
|
| LP32699-8 |
metyraPONE |
|
| LP32704-6 |
Secretin |
|
| LP32705-3 |
TOLBUTamide |
|
| LP32711-1 |
immediately after addition of factor V depleted plasma |
|
| LP32712-9 |
immediately after addition of factor IX depleted plasma |
|
| LP32713-7 |
immediately after addition of factor XIII depleted plasma |
|
| LP32714-5 |
immediately after addition of factor X depleted plasma |
|
| LP32715-2 |
immediately after addition of factor II depleted plasma |
|
| LP32716-0 |
immediately after addition of factor XI depleted plasma |
|
| LP32717-8 |
immediately after addition of factor XII depleted plasma |
|
| LP33014-9 |
0.10% sodium chloride 24H 37 deg C incubation |
|
| LP33015-6 |
0.10% sodium chloride |
|
| LP33016-4 |
0.20% sodium chloride 24H 37 deg C incubation |
|
| LP33017-2 |
0.20% sodium chloride |
|
| LP33161-8 |
5th specimen post dose sincalide |
|
| LP33162-6 |
4th specimen post dose sincalide |
|
| LP33163-4 |
3rd specimen post dose sincalide |
|
| LP33164-2 |
2nd specimen post dose sincalide |
|
| LP33165-9 |
1st specimen post dose sincalide |
|
| LP33221-0 |
post reanastomosis |
|
| LP33254-1 |
6H post XXX bentiromide PO |
|
| LP33263-2 |
10M post excision |
|
| LP33383-8 |
W contrast |
|
| LP33384-6 |
W contrast IA |
|
| LP33385-3 |
W contrast IV |
|
| LP33392-9 |
WO contrast |
|
| LP33407-5 |
W contrast IS |
|
| LP33408-3 |
W contrast IT |
|
| LP33535-3 |
W anesthesia |
|
| LP33538-7 |
W contrast PO |
|
| LP33557-7 |
W gastrografin PO |
|
| LP33650-0 |
W radionuclide IV |
|
| LP33651-8 |
W contrast PR |
|
| LP33654-2 |
W contrast PO during swallowing |
|
| LP33955-3 |
W Tc-99m IV |
|
| LP33957-9 |
W Tc-99m |
|
| LP33958-7 |
W Tc-99m MAA IV |
|
| LP33961-1 |
W Tc-99m pertechnetate IV |
|
| LP33992-6 |
W manual stress |
|
| LP34036-1 |
during surgery |
|
| LP34055-1 |
W contrast percutaneous |
|
| LP34082-5 |
W weight |
|
| LP34196-3 |
W expiration |
|
| LP34197-1 |
W inspiration |
|
| LP34201-1 |
W cholecystokinin |
|
| LP34214-4 |
W contrast intra bladder |
|
| LP34228-4 |
Sincalide |
|
| LP34255-7 |
W air |
|
| LP34258-1 |
W contrast intra duct |
|
| LP34265-6 |
W contrast antegrade |
|
| LP34306-8 |
5M post excision |
|
| LP34578-2 |
pre dose |
|
| LP34579-0 |
30M post dose |
|
| LP34580-8 |
1H post dose |
|
| LP34581-6 |
1.5H post dose |
|
| LP34582-4 |
2.5H post dose |
|
| LP34689-7 |
post washing |
|
| LP34690-5 |
pre washing |
|
| LP34729-1 |
pre or post dose dexamethasone |
|
| LP34756-4 |
W flexion |
|
| LP34757-2 |
W extension |
|
| LP34761-4 |
W R-bending |
|
| LP34762-2 |
W L-bending |
|
| LP34898-4 |
W flexion + W extension |
|
| LP34945-3 |
W R-bending + W L-bending |
|
| LP34953-7 |
pre {event} |
|
| LP34954-5 |
post {event} |
|
| LP34960-2 |
at time of {event} |
|
| LP35145-9 |
W air contrast PO |
|
| LP35298-6 |
48H post contrast PO |
|
| LP35299-4 |
1st specimen post dose lactose |
|
| LP35300-0 |
2nd specimen post dose lactose |
|
| LP35301-8 |
3rd specimen post dose lactose |
|
| LP35311-7 |
W Tl-201 IV |
|
| LP35313-3 |
W Tc-99m DTPA IV |
|
| LP35315-8 |
W Tc-99m Tetrofosmin IV |
|
| LP35316-6 |
W dipyridamole IV+W radionuclide IV |
|
| LP35317-4 |
W adenosine+W Tl-201 IV |
|
| LP35322-4 |
W Tc-99m Sestamibi IV |
|
| LP35331-5 |
W stress+W radionuclide IV |
|
| LP35352-1 |
W adenosine+W radionuclide IV |
|
| LP35355-4 |
W dipyridamole IV+W Tc-99m Sestamibi IV |
|
| LP35360-4 |
W stress+W Tl-201 IV |
|
| LP35365-3 |
at rest+W stress+W Tl-201 IV |
|
| LP35369-5 |
W stress+W Tc-99m Sestamibi IV |
|
| LP35373-7 |
W Tc-99m Mertiatide IV |
|
| LP35400-8 |
W radionuclide gaseous IH |
|
| LP35404-0 |
W radionuclide IH |
|
| LP35458-6 |
W particulate radionuclide IV |
|
| LP35471-9 |
1.5H pre XXX challenge |
|
| LP35472-7 |
1H pre XXX challenge |
|
| LP35473-5 |
45M pre XXX challenge |
|
| LP35474-3 |
5.25H post XXX challenge |
|
| LP35475-0 |
16H post XXX challenge |
|
| LP35476-8 |
18H post XXX challenge |
|
| LP35477-6 |
7D post XXX challenge |
|
| LP35478-4 |
2.25H pre XXX challenge |
|
| LP35480-0 |
5M pre XXX challenge |
|
| LP35481-8 |
100M post XXX challenge |
|
| LP35482-6 |
110M post XXX challenge |
|
| LP35483-4 |
8.5H post XXX challenge |
|
| LP35484-2 |
9.5H post XXX challenge |
|
| LP35485-9 |
11.5H post XXX challenge |
|
| LP35486-7 |
12.5H post XXX challenge |
|
| LP35487-5 |
13H post XXX challenge |
|
| LP35488-3 |
13.5H post XXX challenge |
|
| LP35489-1 |
14H post XXX challenge |
|
| LP35490-9 |
15.5H post XXX challenge |
|
| LP35491-7 |
17.5H post XXX challenge |
|
| LP35492-5 |
18.5H post XXX challenge |
|
| LP35493-3 |
19.5H post XXX challenge |
|
| LP35494-1 |
20H post XXX challenge |
|
| LP35495-8 |
20.5H post XXX challenge |
|
| LP35496-6 |
21.5H post XXX challenge |
|
| LP35497-4 |
22H post XXX challenge |
|
| LP35498-2 |
23.5H post XXX challenge |
|
| LP35499-0 |
3M post XXX challenge |
|
| LP35500-5 |
6M post XXX challenge |
|
| LP35501-3 |
9M post XXX challenge |
|
| LP35502-1 |
12M post XXX challenge |
|
| LP35503-9 |
14M post XXX challenge |
|
| LP35504-7 |
16M post XXX challenge |
|
| LP35505-4 |
27M post XXX challenge |
|
| LP35506-2 |
25H post XXX challenge |
|
| LP35507-0 |
26H post XXX challenge |
|
| LP35508-8 |
27H post XXX challenge |
|
| LP35509-6 |
28H post XXX challenge |
|
| LP35510-4 |
29H post XXX challenge |
|
| LP35511-2 |
30H post XXX challenge |
|
| LP35512-0 |
31H post XXX challenge |
|
| LP35513-8 |
36H post XXX challenge |
|
| LP35514-6 |
3D post XXX challenge |
|
| LP35515-3 |
2H pre XXX challenge |
|
| LP35516-1 |
10.75H post XXX challenge |
|
| LP35517-9 |
20M pre XXX challenge |
|
| LP35518-7 |
13M pre XXX challenge |
|
| LP35519-5 |
8M pre XXX challenge |
|
| LP35520-3 |
3M pre XXX challenge |
|
| LP35522-9 |
pre-meal |
|
| LP35523-7 |
10.5H post XXX challenge |
|
| LP35524-5 |
75M post dose glucose |
|
| LP35525-2 |
105M post dose glucose |
|
| LP35526-0 |
pre dose cloNIDine |
|
| LP35527-8 |
1H post dose cloNIDine |
|
| LP35528-6 |
1.5H post dose cloNIDine |
|
| LP35529-4 |
2H post dose cloNIDine |
|
| LP35530-2 |
pre dose arginine |
|
| LP35531-0 |
1H post dose arginine |
|
| LP35532-8 |
1.5H post dose arginine |
|
| LP35533-6 |
2H post dose arginine |
|
| LP35534-4 |
3H post dose arginine |
|
| LP35535-1 |
3.5H post dose arginine |
|
| LP35536-9 |
4H post dose arginine |
|
| LP35537-7 |
pre dose triple bolus |
|
| LP35538-5 |
15M post dose triple bolus |
|
| LP35539-3 |
30M post dose triple bolus |
|
| LP35540-1 |
45M post dose triple bolus |
|
| LP35541-9 |
1H post dose triple bolus |
|
| LP35542-7 |
1.5H post dose triple bolus |
|
| LP35543-5 |
2H post dose triple bolus |
|
| LP35544-3 |
3H post dose triple bolus |
|
| LP35545-0 |
20M post dose triple bolus |
|
| LP35585-6 |
immediately after addition of factor VIII depleted plasma |
|
| LP35605-2 |
50 umol/L |
|
| LP35606-0 |
100 umol/L |
|
| LP35608-6 |
resting |
|
| LP35615-1 |
post concentration |
|
| LP35616-9 |
unincubated |
|
| LP35651-6 |
pre dose dexamethasone |
|
| LP35659-9 |
2.25H post XXX challenge |
|
| LP35660-7 |
3.75H post XXX challenge |
|
| LP35667-2 |
I-123 |
|
| LP35672-2 |
Xe-133 |
|
| LP35674-8 |
SM 153 |
|
| LP35683-9 |
Adenosine |
|
| LP35684-7 |
Dipyridamole |
|
| LP35685-4 |
DOBUTamine |
|
| LP35687-0 |
In-111 |
|
| LP35689-6 |
W DOBUTamine+W radionuclide IV |
|
| LP35711-8 |
2H post 50 g glucose PO |
|
| LP35732-4 |
2D post dose trichophyton ID |
|
| LP35733-2 |
1D post dose trichophyton ID |
|
| LP35734-0 |
2D post dose mumps ID |
|
| LP35735-7 |
1D post mumps ID |
|
| LP35736-5 |
2D post dose Candida albicans ID |
|
| LP35737-3 |
1D post dose Candida albicans ID |
|
| LP35738-1 |
2D post dose histoplasmin ID |
|
| LP35739-9 |
5H post dose xylose PO |
|
| LP35740-7 |
30M post dose xylose PO |
|
| LP35757-1 |
post dose metyraPONE |
|
| LP35787-8 |
pre dose corticotropin |
|
| LP35833-0 |
pre CFst |
|
| LP35834-8 |
5H post 5 g xylose PO |
|
| LP35887-6 |
20M post collection |
|
| LP36067-4 |
W Xe-133 IH |
|
| LP36087-2 |
sitting |
|
| LP36090-6 |
W standing + W R-bending |
|
| LP36095-5 |
W R-bending + W L-bending + WO bending |
|
| LP36096-3 |
W L-bending + WO bending |
|
| LP36165-6 |
6H post dose lactose PO |
|
| LP36174-8 |
3H post incubation |
|
| LP36175-5 |
1D post incubation |
|
| LP36188-8 |
W barium contrast PO |
|
| LP36341-3 |
Incubation |
|
| LP36416-3 |
15M post dose corticotropin IM |
|
| LP36489-0 |
3D post 1 TU ID |
|
| LP36512-9 |
2H post contrast retrograde |
|
| LP36513-7 |
15M post contrast retrograde |
|
| LP36514-5 |
30M post contrast retrograde |
|
| LP36515-2 |
45M post contrast retrograde |
|
| LP36516-0 |
1H post contrast retrograde |
|
| LP36517-8 |
1.5H post contrast retrograde |
|
| LP36546-7 |
W stress |
|
| LP36557-4 |
W gastrografin PO+W barium contrast PR |
|
| LP36643-2 |
20M post incubation |
|
| LP36644-0 |
4H post incubation |
|
| LP36700-0 |
W barium contrast PR |
|
| LP36810-7 |
post dose dexamethasone |
|
| LP36811-5 |
1.5H post meal |
|
| LP36812-3 |
15M pre dose TRH IV |
|
| LP36838-8 |
12 AM specimen |
|
| LP36839-6 |
12 PM specimen |
|
| LP36840-4 |
8 AM specimen |
|
| LP36841-2 |
8 PM specimen |
|
| LP40260-9 |
post phlebotomy |
|
| LP40291-4 |
overnight |
|
| LP40300-3 |
after addition of heparinase |
|
| LP40351-6 |
post transfusion reaction |
|
| LP40361-5 |
W reduced contrast volume IV |
|
| LP40365-6 |
W air contrast PR |
|
| LP40368-0 |
W standing + W flexion |
|
| LP40378-9 |
15M post 1 ug/kg CRH IV |
|
| LP40379-7 |
1.5H post 1 ug/kg CRH IV |
|
| LP40380-5 |
2H post 1 ug/kg CRH IV |
|
| LP40381-3 |
2H post dose insulin IV |
|
| LP40382-1 |
30M pre 1 g/kg glucose PO |
|
| LP40383-9 |
30M post 1 g/kg glucose PO |
|
| LP40384-7 |
1.5H post 1 g/kg glucose PO |
|
| LP40385-4 |
15M pre dose arginine |
|
| LP40386-2 |
15M post dose arginine |
|
| LP40387-0 |
30M post dose arginine |
|
| LP40388-8 |
45M post dose arginine |
|
| LP40389-6 |
105M post dose arginine |
|
| LP40390-4 |
7M post 0.5 ug/kg pentagastrin IV |
|
| LP40391-2 |
8H post 8 mg dexamethasone PO overnight high dose |
|
| LP40395-3 |
15M post 25 g xylose PO |
|
| LP40396-1 |
post 50 g lactose PO |
|
| LP40397-9 |
post 10 g lactulose PO |
|
| LP40498-5 |
immediately after addition of bovine thrombin |
|
| LP410807-4 |
during exercise |
|
| LP411004-7 |
with use of upper extremities |
|
| LP411053-4 |
post heparin neutralization |
|
| LP411123-5 |
immediately after 1:1 addition of normal plasma+heparin neutralization |
|
| LP411259-7 |
peak during exercise |
|
| LP411498-1 |
4H post busulfan infusion completion |
|
| LP411499-9 |
2H post busulfan infusion completion |
|
| LP411500-4 |
1H post busulfan infusion completion |
|
| LP411501-2 |
immediately post busulfan infusion completion |
|
| LP411858-6 |
15 ug/mL |
|
| LP412060-8 |
post hematopoietic stem cell transplant |
|
| LP412073-1 |
during infancy |
|
| LP412118-4 |
during activity |
|
| LP412119-2 |
during swimming |
|
| LP412120-0 |
during cycling |
|
| LP412121-8 |
during running |
|
| LP412122-6 |
during walking |
|
| LP412123-4 |
during aerobic activity |
|
| LP412124-2 |
during weight training |
|
| LP412125-9 |
while playing a sport |
|
| LP412219-0 |
2H post dose vasopressin |
|
| LP412220-8 |
1H post dose vasopressin |
|
| LP412228-1 |
1H specimen |
|
| LP412229-9 |
W contrast IA & Guidance for percutaneous transluminal angioplasty |
|
| LP412254-7 |
pre dose carbohydrate |
|
| LP412255-4 |
post dose carbohydrate |
|
| LP412256-2 |
15M post dose carbohydrate |
|
| LP412257-0 |
30M post dose carbohydrate |
|
| LP412258-8 |
45M post dose carbohydrate |
|
| LP412259-6 |
1H post dose carbohydrate |
|
| LP412260-4 |
1.5H post dose carbohydrate |
|
| LP412261-2 |
2H post dose carbohydrate |
|
| LP412323-0 |
Vasopressin |
|
| LP412324-8 |
Carbohydrate |
|
| LP416906-8 |
Busulfan |
|
| LP417633-7 |
1 umol/L |
|
| LP417634-5 |
0.5 umol/L |
|
| LP417635-2 |
0.6 umol/L |
|
| LP417636-0 |
1.2 umol/L |
|
| LP417637-8 |
375 ug/mL |
|
| LP417649-3 |
post DOAC neutralization |
|
| LP417729-3 |
corrected |
|
| LP417750-9 |
2D post tetanus toxoid ID |
|
| LP417751-7 |
1D post tetanus toxoid ID |
|
| LP417755-8 |
1D post control ID |
|
| LP417756-6 |
2D post control ID |
|
| LP418559-3 |
5H post meal |
|
| LP418560-1 |
15M post meal |
|
| LP418561-9 |
30M post meal |
|
| LP418562-7 |
2.5H post meal |
|
| LP418563-5 |
3H post meal |
|
| LP418564-3 |
3.5H post meal |
|
| LP418565-0 |
4H post meal |
|
| LP418566-8 |
4.5H post meal |
|
| LP418799-5 |
post secretin |
|
| LP420078-0 |
90M post dose macimorelin |
|
| LP420079-8 |
60M post dose macimorelin |
|
| LP420080-6 |
45M post dose macimorelin |
|
| LP420081-4 |
30M post dose macimorelin |
|
| LP420100-2 |
30M post sham feeding |
|
| LP420101-0 |
5M post sham feeding |
|
| LP420102-8 |
15M post sham feeding |
|
| LP420103-6 |
25M post sham feeding |
|
| LP420104-4 |
10M post sham feeding |
|
| LP420105-1 |
20M post sham feeding |
|
| LP420288-5 |
10% glucose 48H 37 deg C incubation |
|
| LP420754-6 |
post thyroglobulin antibody neutralization |
|
| LP420773-6 |
compensated |
|
| LP420986-4 |
1H post incubation after 1:1 addition of normal plasma |
|
| LP420987-2 |
2H post incubation after 1:1 addition of normal plasma |
|
| LP421835-2 |
Macimorelin |
|
| LP426375-4 |
at end expiration-Carbon dioxide |
|
| LP426526-2 |
after addition of factor VIII Ab |
|
| LP426984-3 |
with Chromogenic agar |
|
| LP426985-0 |
with canavanine glycine+bromothymol blue |
|
| LP426986-8 |
with Sabouraud Dextrose Agar |
|
| LP428586-4 |
click |
|
| LP429120-1 |
post repetitive stimulation |
|
| LP429499-9 |
5M post dose |
|
| LP429617-6 |
18H post dose |
|
| LP431244-5 |
post transplant |
|
| LP431365-8 |
post kidney transplant |
|
| LP431366-6 |
post lung transplant |
|
| LP431367-4 |
post cardiac transplant |
|
| LP432223-8 |
W 90 degree flexion |
|
| LP432225-3 |
W full extension |
|
| LP432799-7 |
after stimulation with SARS-CoV-2 Spike peptide |
|
| LP432806-0 |
after stimulation with SARS-CoV-2 Nucleocapsid peptide |
|
| LP433338-3 |
fetus |
|
| LP433339-1 |
corrected for Cholesterol.in lipoprotein (little a) |
|
| LP433340-9 |
^7th specimen post XXX challenge |
|
| LP434458-8 |
2H post baseline measurement |
|
| LP61647-1 |
Lactulose |
|
| LP61750-3 |
1M post dose glucose |
|
| LP61751-1 |
3M post dose glucose |
|
| LP61752-9 |
5M post dose glucose |
|
| LP61753-7 |
5m pre dose glucose |
|
| LP61754-5 |
pre dose glucagon |
|
| LP61755-2 |
pre dose glucose |
|
| LP61756-0 |
2.5H post 100 ug luteinizing releasing hormone IV |
|
| LP61757-8 |
10M post dose glucagon |
|
| LP61758-6 |
15M post dose glucagon |
|
| LP61760-2 |
pre 100 ug luteinizing releasing hormone IV |
|
| LP61761-0 |
2H post dose calcium |
|
| LP61762-8 |
4H post dose calcium |
|
| LP61763-6 |
pre dose calcium |
|
| LP61764-4 |
1.5H post dose glucagon |
|
| LP61765-1 |
1.5H post dose glucose PO |
|
| LP61766-9 |
10M post dose TRH |
|
| LP61767-7 |
15M post dose insulin IV |
|
| LP61768-5 |
1H post dose glucose PO |
|
| LP61769-3 |
2H post dose glucose PO |
|
| LP61770-1 |
30M post dose glucose PO |
|
| LP61771-9 |
3H post dose glucose PO |
|
| LP61772-7 |
pre dose glucose PO |
|
| LP61804-8 |
6M post dose glucagon |
|
| LP61826-1 |
4M post 1 mg glucagon |
|
| LP61827-9 |
8M post dose glucagon |
|
| LP61828-7 |
post 1 mg dexamethasone PO overnight |
|
| LP61829-5 |
post 2 mg dexamethasone PO 2.5 day high dose q6h |
|
| LP61830-3 |
post 500 ug dexamethasone PO 2.5 day low dose q6h |
|
| LP61831-1 |
post dose corticotropin |
|
| LP61832-9 |
pre 250 ug corticotropin |
|
| LP61834-5 |
1.5H post dose metoclopramide |
|
| LP61835-2 |
1H post dose metoclopramide |
|
| LP61836-0 |
2.5H post dose TRH IV |
|
| LP61837-8 |
30M post dose metoclopramide |
|
| LP61838-6 |
pre dose metoclopramide |
|
| LP61839-4 |
1.5H post dose arginine+insulin |
|
| LP61840-2 |
1.5H post dose betaxolol+glucagon |
|
| LP61841-0 |
1.5H post dose ornithine |
|
| LP61842-8 |
1.75H post dose arginine+insulin |
|
| LP61843-6 |
1.75H post dose ornithine |
|
| LP61844-4 |
15M post dose arginine+insulin |
|
| LP61845-1 |
15M post dose growth hormone releasing factor |
|
| LP61846-9 |
15M post dose ornithine |
|
| LP61847-7 |
1H post dose glucagon |
|
| LP61848-5 |
1H post dose growth hormone releasing factor |
|
| LP61849-3 |
1H post dose ornithine |
|
| LP61850-1 |
1H post dose propranolol+glucagon |
|
| LP61851-9 |
2.25H post dose arginine+insulin |
|
| LP61852-7 |
2.5H post dose propranolol+glucagon |
|
| LP61853-5 |
2H post dose arginine+insulin |
|
| LP61854-3 |
2H post dose betaxolol+glucagon |
|
| LP61855-0 |
2H post dose glucagon |
|
| LP61856-8 |
2H post dose growth hormone releasing factor |
|
| LP61857-6 |
2H post dose ornithine |
|
| LP61858-4 |
2H post dose propranolol+glucagon |
|
| LP61859-2 |
2H pre dose propranolol+glucagon |
|
| LP61860-0 |
30M post dose arginine+insulin |
|
| LP61861-8 |
30M post dose betaxolol+glucagon |
|
| LP61862-6 |
30M post dose glucagon |
|
| LP61863-4 |
30M post dose growth hormone releasing factor |
|
| LP61864-2 |
30M post dose ornithine |
|
| LP61865-9 |
3H post dose betaxolol+glucagon |
|
| LP61866-7 |
3H post dose glucagon |
|
| LP61867-5 |
3H post dose propranolol+glucagon |
|
| LP61868-3 |
45M post dose arginine+insulin |
|
| LP61869-1 |
45M post dose glucagon |
|
| LP61870-9 |
45M post dose growth hormone releasing factor |
|
| LP61871-7 |
45M post dose ornithine |
|
| LP61872-5 |
5M post dose arginine |
|
| LP61873-3 |
5M post dose arginine+insulin |
|
| LP61874-1 |
5M post dose ornithine |
|
| LP61875-8 |
1H post dose betaxolol+glucagon |
|
| LP61876-6 |
pre dose arginine+insulin |
|
| LP61877-4 |
pre dose betaxolol+glucagon |
|
| LP61878-2 |
pre dose growth hormone releasing factor |
|
| LP61879-0 |
pre dose ornithine |
|
| LP61880-8 |
pre dose propranolol+glucagon |
|
| LP61881-6 |
12H post 5000 U HCG IM |
|
| LP61882-4 |
1D post 5000 U HCG IM |
|
| LP61883-2 |
2D post 5000 U HCG IM |
|
| LP61884-0 |
4H post 5000 U HCG IM |
|
| LP61885-7 |
3D post 5000 U HCG IM |
|
| LP61886-5 |
1.5H post dose luteinizing releasing hormone IV |
|
| LP61887-3 |
15M post dose luteinizing releasing hormone IV |
|
| LP61888-1 |
15M pre dose luteinizing releasing hormone IV |
|
| LP61889-9 |
1H post dose luteinizing releasing hormone IV |
|
| LP61890-7 |
2H post dose luteinizing releasing hormone IV |
|
| LP61891-5 |
30M post dose luteinizing releasing hormone IV |
|
| LP61892-3 |
pre dose luteinizing releasing hormone IV |
|
| LP62172-9 |
2.5H post dose arginine+insulin |
|
| LP62173-7 |
2.5H post dose betaxolol+glucagon |
|
| LP62174-5 |
2.5H post dose glucagon |
|
| LP62175-2 |
2.5H post dose luteinizing releasing hormone IV |
|
| LP62177-8 |
15M pre 1 ug/kg CRH IV |
|
| LP62178-6 |
4 AM specimen |
|
| LP62179-4 |
15M pre 100 ug luteinizing releasing hormone IV |
|
| LP62181-0 |
10M pre dose glucose |
|
| LP62182-8 |
15M post dose TRH |
|
| LP62183-6 |
15M pre dose arginine+insulin |
|
| LP62184-4 |
15M pre dose glucagon |
|
| LP62185-1 |
15M pre dose insulin IV |
|
| LP62186-9 |
15M pre dose ornithine |
|
| LP62187-7 |
15M pre dose TRH |
|
| LP62188-5 |
1H post dose arginine+insulin |
|
| LP62189-3 |
30M pre dose betaxolol+glucagon |
|
| LP62190-1 |
30M pre dose propranolol+glucagon |
|
| LP62191-9 |
30M pre dose TRH |
|
| LP62762-7 |
on cycle day 10 |
|
| LP62763-5 |
on cycle day 11 |
|
| LP62764-3 |
on cycle day 21 |
|
| LP62765-0 |
on cycle day 3 |
|
| LP62798-1 |
after addition of APC |
|
| LP62807-0 |
1H post dose fructose PO |
|
| LP62808-8 |
pre dose fructose PO |
|
| LP62809-6 |
30M post dose fructose PO |
|
| LP62815-3 |
24H post peritoneal dialysis |
|
| LP62876-5 |
post bone marrow transplant |
|
| LP62893-0 |
pre therapeutic phlebotomy |
|
| LP62990-4 |
Arginine+Insulin |
|
| LP62991-2 |
Betaxolol+Glucagon |
|
| LP62994-6 |
Metoclopramide |
|
| LP62995-3 |
Ornithine |
|
| LP62996-1 |
Fructose |
|
| LP62997-9 |
Propranolol+Glucagon |
|
| LP62999-5 |
fructose PO |
|
| LP63000-1 |
Dexamethasone PO |
|
| LP63004-3 |
glucose PO |
|
| LP63005-0 |
Growth hormone releasing factor |
|
| LP63006-8 |
15M pre dose glucose |
|
| LP63178-5 |
5H post 50 g glucose PO |
|
| LP63588-5 |
6 PM specimen |
|
| LP63589-3 |
10 PM specimen |
|
| LP63590-1 |
3 AM specimen |
|
| LP63591-9 |
6 AM specimen |
|
| LP63619-8 |
post excision |
|
| LP64253-5 |
Cycle day |
|
| LP64445-7 |
1800 ug/mL |
|
| LP64753-4 |
7D post incubation |
|
| LP64754-2 |
5D post incubation |
|
| LP64755-9 |
3D post incubation |
|
| LP64759-1 |
post 75 g glucose PO |
|
| LP64760-9 |
post 100 g glucose PO |
|
| LP64865-6 |
after addition of normal plasma 1H post incubation separate tubes |
|
| LP64994-4 |
6D post incubation |
|
| LP65012-4 |
1 AM specimen |
|
| LP65013-2 |
1.30 AM specimen |
|
| LP65014-0 |
10.30 PM specimen |
|
| LP65015-7 |
11.30 PM specimen |
|
| LP65016-5 |
12.30 PM specimen |
|
| LP65017-3 |
2 AM specimen |
|
| LP65018-1 |
2.30 AM specimen |
|
| LP65019-9 |
3.30 AM specimen |
|
| LP65020-7 |
4.30 AM specimen |
|
| LP65021-5 |
5 AM specimen |
|
| LP65022-3 |
5.30 AM specimen |
|
| LP65141-1 |
45M post 250 ug corticotropin |
|
| LP65142-9 |
2D post dose dexamethasone |
|
| LP65146-0 |
pre dose ifosfamide |
|
| LP65149-4 |
10M post 2 mg/kg calcium & 0.5 ug/kg pentagastrin IV |
|
| LP65150-2 |
5M post 2 mg/kg calcium & 0.5 ug/kg pentagastrin IV |
|
| LP65151-0 |
2M post 2 mg/kg calcium & 0.5 ug/kg pentagastrin IV |
|
| LP65152-8 |
1M post 2 mg/kg calcium & 0.5 ug/kg pentagastrin IV |
|
| LP65153-6 |
pre 2 mg/kg calcium & 0.5 ug/kg pentagastrin IV |
|
| LP65277-3 |
10th specimen |
|
| LP65281-5 |
9th specimen |
|
| LP65305-2 |
post high dose dexamethasone |
|
| LP65306-0 |
2D post high dose dexamethasone |
|
| LP65307-8 |
1st specimen post CFst |
|
| LP65308-6 |
2nd specimen post CFst |
|
| LP65309-4 |
3rd specimen post CFst |
|
| LP65310-2 |
post 25 mg captopril PO |
|
| LP65311-0 |
pre 25 mg captopril PO |
|
| LP65313-6 |
4th specimen post CFst |
|
| LP65314-4 |
5th specimen post CFst |
|
| LP65321-9 |
1D post dose ifosfamide |
|
| LP65322-7 |
2D post dose ifosfamide |
|
| LP65323-5 |
3D post dose ifosfamide |
|
| LP65324-3 |
4D post dose ifosfamide |
|
| LP65325-0 |
5D post dose ifosfamide |
|
| LP65326-8 |
3H post dose ifosfamide |
|
| LP65327-6 |
6H post dose ifosfamide |
|
| LP65330-0 |
6D post dose ifosfamide |
|
| LP65489-4 |
post transfusion |
|
| LP65490-2 |
pre transfusion |
|
| LP65511-5 |
pre 2 mg dexamethasone PO overnight |
|
| LP65512-3 |
post 2 mg dexamethasone PO overnight |
|
| LP65513-1 |
pre 100 ug CRH IV |
|
| LP65514-9 |
20M post 100 ug CRH IV |
|
| LP65515-6 |
40M post 100 ug CRH IV |
|
| LP65516-4 |
1H post 100 ug CRH IV |
|
| LP65517-2 |
9 AM specimen |
|
| LP65518-0 |
9 PM specimen |
|
| LP65519-8 |
30M pre dose insulin IV |
|
| LP65520-6 |
20M post dose insulin IV |
|
| LP65521-4 |
30M pre dose arginine |
|
| LP65522-2 |
20M post dose arginine |
|
| LP65695-6 |
2H post dose metyraPONE |
|
| LP65731-9 |
15M post 0.1 U/kg insulin |
|
| LP65832-5 |
Ifosfamide |
|
| LP65867-1 |
20 umol/L |
|
| LP65868-9 |
2 umol/L |
|
| LP65869-7 |
4 umol/L |
|
| LP65870-5 |
190 ug/mL |
|
| LP66388-7 |
4H post dose |
|
| LP66389-5 |
3H post dose xylose PO |
|
| LP66391-1 |
after addition of 1:4 normal plasma 1H post incubation separate tubes |
|
| LP66600-5 |
afternoon |
|
| LP66651-8 |
2.5H post dose fructose PO |
|
| LP66652-6 |
1.5H post dose fructose PO |
|
| LP66653-4 |
3H post dose fructose PO |
|
| LP66654-2 |
2H post dose fructose PO |
|
| LP66705-2 |
10 umol/L |
|
| LP66772-2 |
immediately after addition of XXX |
|
| LP66862-1 |
Incubated. |
|
| LP66865-4 |
I-131 |
|
| LP68313-3 |
0.90% sodium chloride |
|
| LP68314-1 |
0.90% sodium chloride 24H 37 deg C incubation |
|
| LP68319-0 |
immediately after 4:1 addition of normal plasma |
|
| LP69297-7 |
after addition of protein C activator+factor V depleted plasma |
|
| LP69298-5 |
after addition of protein C activator |
|
| LP70438-4 |
post dose deferoxamine |
|
| LP70440-0 |
pre dose betaxolol |
|
| LP70441-8 |
2H post dose betaxolol |
|
| LP70442-6 |
2.5H post dose betaxolol |
|
| LP70443-4 |
15M pre dose betaxolol |
|
| LP70444-2 |
3H post dose betaxolol |
|
| LP70445-9 |
30M post dose betaxolol |
|
| LP70446-7 |
30M pre dose betaxolol |
|
| LP70447-5 |
45M post dose betaxolol |
|
| LP70448-3 |
1H post dose betaxolol |
|
| LP70449-1 |
1.5H post dose betaxolol |
|
| LP70547-2 |
20 umol/mL |
|
| LP70548-0 |
50 umol/mL |
|
| LP70549-8 |
100 umol/mL |
|
| LP70550-6 |
8.0 ug/mL |
|
| LP70551-4 |
0.1 ug/mL |
|
| LP70552-2 |
500 ug/mL |
|
| LP70553-0 |
800 ug/mL |
|
| LP70622-3 |
Betaxolol |
|
| LP70623-1 |
Deferoxamine |
|
| LP71232-0 |
2.75H post XXX challenge |
|
| LP71233-8 |
1.75H post XXX challenge |
|
| LP71234-6 |
1.25H post XXX challenge |
|
| LP71577-8 |
20M post 50 g lactose PO |
|
| LP71578-6 |
40M post 50 g lactose PO |
|
| LP71893-9 |
10M post birth |
|
| LP71894-7 |
1M post birth |
|
| LP71895-4 |
5M post birth |
|
| LP71896-2 |
2M post birth |
|
| LP71897-0 |
at 0.5 liter per second on ventilator |
|
| LP71899-6 |
at 1.0 liter per second on ventilator |
|
| LP71901-0 |
at 1.0 s post forced inspiration |
|
| LP71902-8 |
at 1.5 liter per second on ventilator |
|
| LP71903-6 |
at 2.0 liter per second on ventilator |
|
| LP71904-4 |
at 2.5 liter per second on ventilator |
|
| LP71905-1 |
at 25-75% of forced expiration |
|
| LP71907-7 |
at aortic flow measurement |
|
| LP71908-5 |
at maximum voluntary ventilation |
|
| LP71909-3 |
at mean expiratory flow on ventilator |
|
| LP71910-1 |
at peak inspiratory flow max setting |
|
| LP71911-9 |
at peak inspiratory flow setting |
|
| LP71912-7 |
at zero inspiratory flow on ventilator |
|
| LP71914-3 |
during AS max vel measurement |
|
| LP71915-0 |
during MR max vel measurement |
|
| LP71916-8 |
during RVSP max vel measurement |
|
| LP71917-6 |
expiration |
|
| LP71918-4 |
inspiration |
|
| LP71919-2 |
on ventilator |
|
| LP71920-0 |
on ventilator.pressure targeted control |
|
| LP71921-8 |
on ventilator.volume targeted assist & control |
|
| LP71922-6 |
on ventilator.volume targeted control |
|
| LP71923-4 |
post bronchoscopy |
|
| LP71924-2 |
post cardioversion |
|
| LP71925-9 |
post conscious sedation |
|
| LP71926-7 |
post inhalation therapy |
|
| LP71927-5 |
pre arterial puncture |
|
| LP71928-3 |
pre bronchoscopy |
|
| LP71929-1 |
pre cardioversion |
|
| LP71930-9 |
pre conscious sedation |
|
| LP71931-7 |
pre inhalation therapy |
|
| LP71932-5 |
at stenosis |
|
| LP71933-3 |
for peak half-time calculation |
|
| LP71934-1 |
post bronchodilator |
|
| LP71935-8 |
pre bronchodilator |
|
| LP71936-6 |
pre therapy |
|
| LP71937-4 |
at birth |
|
| LP71986-1 |
pre dose methacholine |
|
| LP71989-5 |
post dose methacholine |
|
| LP71990-3 |
25 mg/mL methacholine |
|
| LP71991-1 |
post 2.5 mg/mL methacholine |
|
| LP71992-9 |
post 10 mg/mL methacholine |
|
| LP71993-7 |
post 0.25 mg/mL methacholine |
|
| LP71994-5 |
post 0.025 mg/mL methacholine |
|
| LP71995-2 |
5M post exercise |
|
| LP73890-3 |
at ambulance transport |
|
| LP73891-1 |
after ambulance transport |
|
| LP73892-9 |
before ambulance transport |
|
| LP89273-4 |
immediately after addition of factor V depleted plasma+APC |
|
| LP89275-9 |
24H post dose dexamethasone |
|
| LP89276-7 |
3D post dose dexamethasone |
|
| LP89277-5 |
4D post dose corticotropin |
|
| LP89278-3 |
5D post dose dexamethasone |
|
| LP89279-1 |
5H post dose corticotropin |
|
| LP89352-6 |
9 AM 2nd day specimen |
|
| LP89361-7 |
10M pre dose glucagon |
|
| LP89362-5 |
20M post dose glucagon |
|
| LP89363-3 |
2M post dose glucagon |
|
| LP89364-1 |
4M post dose glucagon |
|
| LP89365-8 |
5M pre dose glucagon |
|
| LP89366-6 |
2.5H post dose insulin IV |
|
| LP89367-4 |
3H pre dose insulin IV |
|
| LP89368-2 |
1.3H post dose insulin IV |
|
| LP89369-0 |
pre dose ornithine alpha-ketoglutarate |
|
| LP89370-8 |
2H post dose ornithine alpha-ketoglutarate |
|
| LP89371-6 |
2.5H post dose ornithine alpha-ketoglutarate |
|
| LP89372-4 |
15M post dose ornithine alpha-ketoglutarate |
|
| LP89373-2 |
15M pre dose ornithine alpha-ketoglutarate |
|
| LP89374-0 |
3H post dose ornithine alpha-ketoglutarate |
|
| LP89375-7 |
30M post dose ornithine alpha-ketoglutarate |
|
| LP89376-5 |
45M post dose ornithine alpha-ketoglutarate |
|
| LP89377-3 |
1H post dose ornithine alpha-ketoglutarate |
|
| LP89378-1 |
1.5H post dose ornithine alpha-ketoglutarate |
|
| LP89386-4 |
ornithine alpha-ketoglutarate |
|
| LP91440-5 |
at mitral flow measurement |
|
| LP91441-3 |
at pulmonic flow measurement |
|
| LP91449-6 |
at tricuspid flow measurement |
|
| LP92686-2 |
during XXX measurement |
|
| LP93357-9 |
post dose dexamethasone PO overnight |
|
| LP93400-7 |
post bronchodilation |
|
| LP93401-5 |
pre bronchodilation |
|
| LP93402-3 |
pre chest physiotherapy |
|
| LP93403-1 |
post chest physiotherapy |
|
| LP93404-9 |
post XXX treatment |
|
| LP93405-6 |
pre XXX treatment |
|
| LP93406-4 |
during bronchodilation |
|
| LP93407-2 |
during chest physiotherapy |
|
| LP93408-0 |
during treatment |
|
| LP93409-8 |
on oxygen.high flow & asleep |
|
| LP93411-4 |
on oxygen.low flow & asleep |
|
| LP93412-2 |
on oxygen.low flow & eating |
|
| LP93413-0 |
on oxygen.low flow & awake |
|
| LP93416-3 |
on room air and asleep |
|
| LP93417-1 |
on room air and awake |
|
| LP93418-9 |
on room air and eating |
|
| LP93419-7 |
post exercise |
|
| LP93420-5 |
post treatment |
|
| LP93515-2 |
during XXX treatment |
|
| LP93749-7 |
head raised 30 degrees |
|
| LP93750-5 |
baseline setting |
|
| LP93751-3 |
post therapy |
|
| LP93754-7 |
during inspiration on ventilator |
|
| LP93755-4 |
on room air |
|
| LP93756-2 |
pre physiotherapy |
|
| LP94239-8 |
5M post incubation after addition of normal plasma |
|
| LP94459-2 |
pre pregnancy |
|
| LP94460-0 |
with clothes |
|
| LP94461-8 |
without clothes |
|
| LP94462-6 |
ante partum |
|
| LP94463-4 |
pre treatment |
|
| LP94464-2 |
on oxygen.high flow & awake |
|
| LP94465-9 |
on oxygen.high flow & eating |
|
| LP94467-5 |
W manual stress) |
|
| LP94468-3 |
standing) |
|
| LP94472-5 |
W R-bending + W L-bending) |
|
| LP94493-1 |
at 1.0 s post forced inspiration/Volume.forced inspiration.total |
|
| LP94495-6 |
post bronchodilator/Voluntary ventilation.max predicted |
|
| LP94496-4 |
pre bronchodilator/Voluntary ventilation.max predicted |
|
| LP94518-5 |
last 20% of breath on ventilator |
|
| LP94519-3 |
post 1.5-2.0 s inspiratory hold on ventilator |
|
| LP94537-5 |
1000 ug/mL |
|
| LP94561-5 |
45M post 75 g glucose PO |
|
| LP94562-3 |
post 4H FFst |
|
| LP94563-1 |
post 7H FFst |
|
| LP94564-9 |
post 5H FFst |
|
| LP94565-6 |
post 3H FFst |
|
| LP94566-4 |
post 2H FFst |
|
| LP94567-2 |
post 1H FFst |
|
| LP94568-0 |
post 6H FFst |
|
| LP94782-7 |
7M post dose glucose IV |
|
| LP94783-5 |
4H post dose glucose IV |
|
| LP94784-3 |
1.5H post dose glucose IV |
|
| LP94785-0 |
10M post dose glucose IV |
|
| LP94786-8 |
1H post dose glucose IV |
|
| LP94787-6 |
1M post dose glucose IV |
|
| LP94788-4 |
2.5H post dose glucose IV |
|
| LP94789-2 |
30M post dose glucose IV |
|
| LP94790-0 |
3H post dose glucose IV |
|
| LP94791-8 |
5M post dose glucose IV |
|
| LP94792-6 |
45M post dose glucose IV |
|
| LP94793-4 |
2H post dose glucose IV |
|
| LP94794-2 |
3M post dose glucose IV |
|
| LP94795-9 |
7M pre dose glucose |
|
| LP94796-7 |
15M post dose glucose IV |
|
| LP94797-5 |
20M post dose TRH IV |
|
| LP94798-3 |
40M post dose TRH IV |
|
| LP94799-1 |
10M post exercise |
|
| LP94800-7 |
45M post dose cloNIDine |
|
| LP94801-5 |
30M post dose cloNIDine |
|
| LP94802-3 |
20M post exercise |
|
| LP94803-1 |
4H post dose gonadotropin releasing hormone |
|
| LP94815-5 |
glucose IV |
|
| LP94820-5 |
On oxygen |
|
| LP94822-1 |
Physiotherapy |
|
| LP94823-9 |
Treatment |
|
| LP94825-4 |
Bronchodilation |
|
| LP94827-0 |
Bronchoscopy |
|
| LP95055-7 |
immediately after 1:2 addition of saline |
|
| LP95056-5 |
immediately after 1:2 addition of platelet lysate |
|
| LP95057-3 |
2.5 umol/L |
|
| LP95058-1 |
5 umol/L |
|
| LP95059-9 |
1125 mg/L |
|
| LP95060-7 |
1000 mg/L |
|
| LP95061-5 |
500 mg/L |
|
| LP95180-3 |
500 umol/L |
|
| LP95181-1 |
1 ug/mL |
|
| LP95182-9 |
5 ug/mL |
|
| LP95183-7 |
250 ug/mL |
|
| LP95185-2 |
5 U/mL |
|
| LP95186-0 |
1 U/mL |
|
| LP95250-4 |
1.0 mg/mL |
|
| LP95302-3 |
at age 25 |
|
| LP95305-6 |
at body weight.max |
|
| LP95309-8 |
at most recent delivery |
|
| LP95326-2 |
pre current pregnancy |
|
| LP95327-0 |
during current pregnancy |
|
| LP95328-8 |
pre most recent pregnancy |
|
| LP95329-6 |
during most recent pregnancy |
|
| LP95330-4 |
XXX time ago |
|
| LP96148-9 |
30M post exercise |
|
| LP96201-6 |
2.17H post XXX challenge |
|
| LP96212-3 |
32H post XXX challenge |
|
| LP96330-3 |
160M post exercise |
|
| LP96331-1 |
3H post exercise |
|
| LP96491-3 |
pre dose lactulose |
|
| LP96492-1 |
1H post dose lactulose |
|
| LP96493-9 |
2H post dose lactulose |
|
| LP96494-7 |
2.5H post dose lactulose |
|
| LP96495-4 |
3.5H post dose lactulose |
|
| LP96496-2 |
1.5H post dose lactulose |
|
| LP96497-0 |
30M post dose lactulose |
|
| LP96498-8 |
64H post XXX challenge |
|
| LP96499-6 |
68H post XXX challenge |
|
| LP96500-1 |
56H post XXX challenge |
|
| LP96501-9 |
60H post XXX challenge |
|
| LP96502-7 |
44H post XXX challenge |
|
| LP96503-5 |
40H post XXX challenge |
|
| LP96504-3 |
post precipitation |
|
| LP96505-0 |
upright+30M post XXX challenge |
|
| LP96506-8 |
upright+1H post XXX challenge |
|
| LP96507-6 |
30M post resting |
|
| LP96508-4 |
90M post resting |
|
| LP96509-2 |
1H post resting |
|
| LP96785-8 |
3H post dose lactulose |
|
| LP97020-9 |
10M pre dose gonadotropin releasing hormone |
|
| LP97021-7 |
20M post dose gonadotropin releasing hormone |
|
| LP97499-5 |
12th specimen |
|
| LP97500-0 |
11th specimen |
|
| LP97503-4 |
3H post dose calcium |
|
| LP97504-2 |
1H post dose calcium |
|
| LP97505-9 |
pre high dose dexamethasone |
|
| LP97506-7 |
1D post dose dexamethasone |
|
| LP97507-5 |
pre dose metyraPONE |
|
| LP97508-3 |
1D post dose metyraPONE |
|
| LP97509-1 |
2D post dose metyraPONE |
|
| LP97510-9 |
1st specimen post dose gonadotropin releasing hormone |
|
| LP97511-7 |
2nd specimen post dose gonadotropin releasing hormone |
|
| LP97512-5 |
3rd specimen post dose gonadotropin releasing hormone |
|
| LP97513-3 |
4th specimen post dose gonadotropin releasing hormone |
|
| LP97514-1 |
5th specimen post dose gonadotropin releasing hormone |
|
| LP97515-8 |
6th specimen post dose gonadotropin releasing hormone |
|
| LP97516-6 |
7th specimen post dose gonadotropin releasing hormone |
|
| LP97518-2 |
3H post 25 mg captopril PO |
|
| LP97521-6 |
190M post XXX challenge |
|
| LP97522-4 |
70M pre XXX challenge |
|
| LP97904-4 |
Conscious sedation |
|
| LP97905-1 |
Cardioversion |
|
| LP97906-9 |
{event} |
|
| LP97908-5 |
Weight |
|
| LP97910-1 |
Surgery |
|
| LP97912-7 |
Ambulance transport |
|
| LP97935-8 |
4th specimen post dose lactose |
|
| LP97936-6 |
5th specimen post dose lactose |
|
| LP98851-6 |
when specimen taken |
|
| LP99377-1 |
7th specimen post CFst |
|
| LP99378-9 |
6th specimen post CFst |
|
| LP99379-7 |
2M post 1 mg glucagon IV |
|
| LP99382-1 |
105M post dose insulin IV |
|
| LP99385-4 |
30M pre 1 ug/kg CRH IV |
|
| LP99386-2 |
30M pre dose glucagon |
|
| LP99387-0 |
3H post dose insulin IV |
|
| LP99389-6 |
75M post dose insulin IV |
|
| LP99539-6 |
13th specimen |
|
| LP99540-4 |
21st specimen |
|
| LP99541-2 |
24th specimen |
|
| LP99542-0 |
23rd specimen |
|
| LP99543-8 |
22nd specimen |
|
| LP99544-6 |
20th specimen |
|
| LP99545-3 |
19th specimen |
|
| LP99546-1 |
18th specimen |
|
| LP99547-9 |
17th specimen |
|
| LP99548-7 |
16th specimen |
|
| LP99549-5 |
14th specimen |
|
| LP99550-3 |
15th specimen |
|
| LP99551-1 |
25th specimen |
|
| LP99552-9 |
post 1.5H FFst |
|
| LP99553-7 |
post 30M FFst |
|
| LP99554-5 |
48th specimen |
|
| LP99555-2 |
47th specimen |
|
| LP99556-0 |
46th specimen |
|
| LP99557-8 |
45th specimen |
|
| LP99558-6 |
44th specimen |
|
| LP99559-4 |
43rd specimen |
|
| LP99560-2 |
42nd specimen |
|
| LP99561-0 |
41st specimen |
|
| LP99562-8 |
39th specimen |
|
| LP99563-6 |
38th specimen |
|
| LP99564-4 |
37th specimen |
|
| LP99565-1 |
36th specimen |
|
| LP99566-9 |
35th specimen |
|
| LP99567-7 |
33rd specimen |
|
| LP99568-5 |
32nd specimen |
|
| LP99569-3 |
31st specimen |
|
| LP99570-1 |
30th specimen |
|
| LP99571-9 |
29th specimen |
|
| LP99572-7 |
28th specimen |
|
| LP99573-5 |
27th specimen |
|
| LP99574-3 |
26th specimen |
|
| LP99663-4 |
40th specimen |
|
| LP99669-1 |
supine+30M post XXX challenge |
|
| LP99674-1 |
34th specimen |
|
| LP99750-9 |
during atrial contraction |
|
| LP100239-5 |
PANEL.SURVEY.MFS |
|
| LP100242-9 |
SURVEY.MFS |
|
| LP101817-7 |
PANEL.TIMP |
|
| LP101819-3 |
TIMP |
|
| LP101870-6 |
IEEE Rosetta |
|
| LP102487-8 |
DOC.EPSOS |
|
| LP102766-5 |
PANEL.SURVEY.PROMIS |
|
| LP102768-1 |
SURVEY.PROMIS |
|
| LP111151-9 |
DOC.ADMIN |
|
| LP111373-9 |
PANEL.HL7.CYTOGEN |
|
| LP111381-2 |
HL7.CYTOGEN |
|
| LP116201-7 |
SURVEY.ESRD |
|
| LP116676-0 |
PANEL.PATH |
|
| LP121006-3 |
PANEL.SURVEY.ESRD |
|
| LP121010-5 |
DOC.PUBLICHEALTH |
|
| LP121011-3 |
MOLPATH.MISC |
|
| LP121306-7 |
CARD.RISK |
|
| LP133214-9 |
NEMSIS |
|
| LP134033-2 |
PANEL.NEMSIS |
|
| LP134157-9 |
PANEL.SURVEY.NEUROQ |
|
| LP134184-3 |
SURVEY.NEUROQ |
|
| LP135481-2 |
SURVEY.CDC |
|
| LP135494-5 |
SURVEY.SAMHSA |
|
| LP135592-6 |
PANEL.SURVEY.SAMHSA |
|
| LP135665-0 |
PANEL.SPEC |
|
| LP135709-6 |
PANEL.SURVEY.CDC |
|
| LP135721-1 |
HRTRATE.PSTN.MOLEC |
|
| LP136009-0 |
SURVEY.CERNER |
|
| LP136321-9 |
SURVEY.OPTIMAL |
|
| LP136325-0 |
PANEL.SURVEY.OPTIMAL |
|
| LP140592-9 |
PANEL.SURVEY.PHQ |
|
| LP145407-5 |
SURVEY.HHS |
|
| LP145577-5 |
PANEL.SURVEY.HHS |
|
| LP145628-6 |
PANEL.PULM |
|
| LP145897-7 |
PANEL.SURVEY.NEURO |
|
| LP145899-3 |
SURVEY.NEURO |
|
| LP145934-8 |
SURVEY.MTLHLTH |
|
| LP145936-3 |
PANEL.SURVEY.MTLHLTH |
|
| LP146061-9 |
MOLPATH.INV |
|
| LP146111-2 |
SURVEY.GNHLTH |
|
| LP146498-3 |
PANEL.SURVEY.GNHLTH |
|
| LP149207-5 |
SURVEY.EPDS |
|
| LP149218-2 |
PANEL.SURVEY.EPDS |
|
| LP149246-3 |
PANEL.SURVEY.CMS |
|
| LP149839-5 |
SURVEY.AAOS |
|
| LP158133-1 |
HNA |
|
| LP171373-6 |
PANEL.HNA |
|
| LP172758-7 |
PANEL.SURVEY.NSRAS |
|
| LP172759-5 |
SURVEY.NSRAS |
|
| LP172861-9 |
CARDIO-PULM |
|
| LP173650-5 |
SURVEY.AHRQ |
|
| LP173666-1 |
ATTACH.PERIODONTAL |
|
| LP173700-8 |
PANEL.SURVEY.AHRQ |
|
| LP174433-5 |
TRAUMA |
|
| LP175679-2 |
H&P.HX.LAB |
|
| LP175703-0 |
SURVEY.MISC |
|
| LP184269-1 |
PANEL.SURVEY.NORTON |
|
| LP184270-9 |
SURVEY.NORTON |
|
| LP184336-8 |
HL7.CCDA |
|
| LP184353-3 |
PANEL.HL7.CCDA |
|
| LP185381-3 |
NUTRITION&DIETETICS |
|
| LP185383-9 |
PANEL.NUTRITION&DIET |
|
| LP185814-3 |
SURVEY.NIH_TOOLBOX |
|
| LP185825-9 |
PANEL.SURVEY.PCORI |
|
| LP185871-3 |
SURVEY.PCORNET |
|
| LP186014-9 |
SURVEY.PAS |
|
| LP186015-6 |
SURVEY.PASII |
|
| LP186067-7 |
SURVEY.COOP |
|
| LP186129-5 |
PANEL.SURVEY.COOP |
|
| LP186131-1 |
PANEL.SURVEY.PAS |
|
| LP186132-9 |
PANEL.SURVEY.PASII |
|
| LP186146-9 |
SURVEY.ADVAULT |
|
| LP186147-7 |
PANEL.SURVEY.ADVAULT |
|
| LP186206-1 |
SURVEY.HAQ |
|
| LP186207-9 |
PANEL.SURVEY.HAQ |
|
| LP186213-7 |
PANEL.SURVEY.PCORNET |
|
| LP186239-2 |
PANEL.IEEE ROSETTA |
|
| LP186995-9 |
ONCOLOGY |
|
| LP186996-7 |
PANEL.ONCO |
|
| LP188761-3 |
APTA |
|
| LP189424-7 |
PANEL.APTA |
|
| LP189609-3 |
SURVEY.HARK |
|
| LP189610-1 |
PANEL.SURVEY.HARK |
|
| LP189611-9 |
PANEL.SURVEY.NHANES |
|
| LP189612-7 |
SURVEY.NHANES |
|
| LP189613-5 |
SURVEY.HWS |
|
| LP190353-5 |
MOLPATH.DELDUP |
|
| LP190498-8 |
Respiratory / Pulmonology |
|
| LP190514-2 |
Ophthalmology / Optometry |
|
| LP190521-7 |
General Behavioral Health / Psychiatry |
|
| LP190540-7 |
Endocrine System |
|
| LP190552-2 |
Renal / Nephrology |
|
| LP190554-8 |
Gastrointestinal System |
|
| LP190563-9 |
Cardiovascular System |
|
| LP191414-4 |
PANEL.SURVEY.IPAQ |
|
| LP191415-1 |
SURVEY.IPAQ |
|
| LP191416-9 |
SURVEY.AMNART |
|
| LP191417-7 |
PANEL.SURVEY.AMNART |
|
| LP191920-0 |
SURVEY.BPI |
|
| LP191921-8 |
PANEL.SURVEY.BPI |
|
| LP193279-9 |
MOLPATH.NUCREPEAT |
|
| LP193345-8 |
Physical Therapy |
|
| LP193853-1 |
SURVEY.NHCS |
|
| LP199487-2 |
SURVEY.ADHD |
|
| LP200139-6 |
SURVEY.GPCOG |
|
| LP200140-4 |
PANEL.SURVEY.GPCOG |
|
| LP200320-2 |
CARD.PROC |
|
| LP201214-6 |
EYE.ERG |
|
| LP201226-0 |
EYE.HX |
|
| LP201883-8 |
NEURO |
|
| LP201887-9 |
IO_IN.INFUS |
|
| LP202929-8 |
MOLPATH.PHARMG |
|
| LP203309-2 |
CARD.US.DICOM |
|
| LP203646-7 |
EYE.ANGIO.NEI |
|
| LP203647-5 |
EYE.EOG.NEI |
|
| LP203648-3 |
EYE.ERG.NEI |
|
| LP203649-1 |
EYE.HX.NEI |
|
| LP203650-9 |
EYE.PX.NEI |
|
| LP203651-7 |
EYE.OCT.NEI |
|
| LP203652-5 |
EYE.REFRACTION.NEI |
|
| LP203653-3 |
EYE.SLITLAMP.NEI |
|
| LP203654-1 |
EYE.TONOMETRY.NEI |
|
| LP203655-8 |
EYE.VISUAL_FIELD.NEI |
|
| LP209048-0 |
SURG |
|
| LP212320-8 |
PANEL.ATTACH.MOD |
|
| LP212450-3 |
PANEL.SURG |
|
| LP212480-0 |
ADMIN.DEMOG |
|
| LP212481-8 |
ADMIN |
|
| LP221227-4 |
SURVEY.ACT |
|
| LP221228-2 |
PANEL.SURVEY.ACT |
|
| LP221229-0 |
PANEL.SURVEY.DAST |
|
| LP230010-3 |
SURVEY.ALSFRSR |
|
| LP230280-2 |
MEDS |
|
| LP231645-5 |
SURVEY.CMS |
|
| LP231796-6 |
CLINTRIAL |
|
| LP232486-3 |
NIH.MOTOR |
|
| LP234174-3 |
CHAL.ROUTINE |
|
| LP234175-0 |
PANEL.UPDRS |
|
| LP234772-4 |
NIH.SENSORY |
|
| LP234847-4 |
PANEL.NIH.MOTOR |
|
| LP234856-5 |
PANEL.NIH.COGNITIVE |
|
| LP234857-3 |
NIH.COGNITIVE |
|
| LP238880-1 |
SURVEY.NIH.EMO |
|
| LP238881-9 |
PANEL.SURVEY.NIH.EMO |
|
| LP241884-8 |
PANEL.MEDS |
|
| LP248518-5 |
SURVEY.MLHFQ |
|
| LP248520-1 |
PANEL.SURVEY.MLHFQ |
|
| LP248694-4 |
ADMIN.FACILITY |
|
| LP248697-7 |
ADMIN.ID |
|
| LP253520-3 |
PANEL.SURVEY.ALSFRSR |
|
| LP253522-9 |
SURVEY.DAST |
|
| LP261286-1 |
PATH.HISTO |
|
| LP262343-9 |
UPDRS |
|
| LP264341-1 |
PANEL.TRAUMA |
|
| LP266551-3 |
AUDIO |
|
| LP266765-9 |
SURVEY.BDI |
|
| LP266766-7 |
PANEL.SURVEY.BDI |
|
| LP266773-3 |
SURVEY.CESD |
|
| LP266774-1 |
PANEL.SURVEY.CESD |
|
| LP267194-1 |
PANEL.ADMIN |
|
| LP267621-3 |
CLIN.RISK |
|
| LP267622-1 |
PANEL.CLIN.RISK |
|
| LP269362-2 |
SURVEY.PEG |
|
| LP270009-6 |
SURVEY.DUKE-AD |
|
| LP270010-4 |
PANEL.SURVEY.DUKE-AD |
|
| LP29659-7 |
ATTACH.CARD |
|
| LP29660-5 |
ATTACH.GI |
|
| LP29661-3 |
ATTACH.OBS |
|
| LP29662-1 |
ATTACH.REHAB.ABUSE |
|
| LP29663-9 |
ATTACH.REHAB.CARDIAC |
|
| LP29664-7 |
ATTACH.REHAB.NURS |
|
| LP29665-4 |
ATTACH.REHAB.OT |
|
| LP29666-2 |
ATTACH.REHAB.PSYCH |
|
| LP29667-0 |
ATTACH.REHAB.PT |
|
| LP29668-8 |
ATTACH.REHAB.RT |
|
| LP29669-6 |
ATTACH.REHAB.SOCIAL |
|
| LP29670-4 |
ATTACH.REHAB.SPEECH |
|
| LP29671-2 |
ATTACH.RESP |
|
| LP29672-0 |
CARD.US |
|
| LP29673-8 |
EYE.CONTACT_LENS |
|
| LP29674-6 |
EYE.GLASSES |
|
| LP29675-3 |
EYE.HETEROPHORIA |
|
| LP29676-1 |
EYE.PX |
|
| LP29677-9 |
EYE.REFRACTION |
|
| LP29678-7 |
EYE.RETINAL_RX |
|
| LP29679-5 |
EYE.TONOMETRY |
|
| LP29680-3 |
EYE.US |
|
| LP29681-1 |
EYE.VISUAL_FIELD |
|
| LP29682-9 |
PANEL.ABXBACT |
|
| LP29683-7 |
PANEL.DRUG/TOX |
|
| LP29687-8 |
SURVEY.NURSE.HHCC |
|
| LP29688-6 |
SURVEY.NURSE.HIV-SSC |
|
| LP29689-4 |
SURVEY.NURSE.LIV-HIV |
|
| LP29690-2 |
SURVEY.NURSE.OMAHA |
|
| LP29691-0 |
SURVEY.NURSE.QAM |
|
| LP29692-8 |
VACCIN |
|
| LP29695-1 |
Attachments |
|
| LP29696-9 |
Survey |
|
| LP29698-5 |
Body circumference |
|
| LP29699-3 |
Body height(length) |
|
| LP29701-7 |
Body temperature |
|
| LP29703-3 |
Body weight |
|
| LP29704-1 |
Blood pressure measurements |
|
| LP29710-8 |
GI |
|
| LP29712-4 |
Hemodyn |
|
| LP29713-2 |
Hrtrate |
|
| LP29718-1 |
Resp |
|
| LP29720-7 |
Urologic |
|
| LP30604-0 |
Body measurements |
|
| LP30605-7 |
Vital signs |
|
| LP31893-8 |
PANEL.COAG |
|
| LP31894-6 |
PANEL.BLDBK |
|
| LP31895-3 |
PANEL.CHAL |
|
| LP31904-3 |
PANEL.VITALS |
|
| LP31905-0 |
PANEL.CARDIAC |
|
| LP31906-8 |
PANEL.IO |
|
| LP31907-6 |
PANEL.BP |
|
| LP32519-8 |
DOC.ONTOLOGY |
|
| LP32520-6 |
DOC.REF |
|
| LP32521-4 |
DOCUMENT.REGULATORY |
|
| LP32523-0 |
GEN.US |
|
| LP33024-8 |
PANEL.H&P |
|
| LP33027-1 |
PANEL.US.URO |
|
| LP33028-9 |
PANEL.BDYTMP |
|
| LP33029-7 |
PANEL.OB.US |
|
| LP33030-5 |
PANEL.FUNCTION |
|
| LP33258-2 |
DOC.REF.CTP |
|
| LP33267-3 |
PANEL.ALLERGY |
|
| LP343406-7 |
Microbiology and Antimicrobial susceptibility |
|
| LP343630-2 |
Lab report general comments |
|
| LP343631-0 |
Chemistry and Chemistry challenge |
|
| LP343632-8 |
BLDBK.GENOTYPING |
|
| LP343633-6 |
ORDEROBSASSOCINFO |
|
| LP343634-4 |
LABADMIN |
|
| LP345096-4 |
PANEL.BLDBK.GENOTYPE |
|
| LP345159-0 |
ADMIN.PATIENT |
|
| LP345160-8 |
ADMIN.PATIENT.ID |
|
| LP35152-5 |
ATTACH.CPHS |
|
| LP35960-1 |
DEVICES |
|
| LP36122-7 |
PATIENT SAFETY |
|
| LP36380-1 |
PANEL.DEVICES |
|
| LP36709-1 |
SURVEY.PHQ |
|
| LP36751-3 |
PATH.PROTOCOLS.GENER |
|
| LP36752-1 |
PATH.PROTOCOLS.PROST |
|
| LP36753-9 |
PATH.PROTOCOLS.BRST |
|
| LP36754-7 |
PATH.PROTOCOLS.SKIN |
|
| LP36771-1 |
TRNSPLNT.ORGAN |
|
| LP36817-2 |
PANEL.HLA |
|
| LP36844-6 |
PANEL.FERT |
|
| LP36900-6 |
PANEL.CELLMARK |
|
| LP40268-2 |
SURVEY.MDS |
|
| LP40269-0 |
PANEL.SURVEY.MDS |
|
| LP40481-1 |
SURVEY.OASIS |
|
| LP40482-9 |
PANEL.SURVEY.OASIS |
|
| LP40485-2 |
PANEL.SURVEY.RFC |
|
| LP40487-8 |
SURVEY.RFC |
|
| LP410757-1 |
ADMIN.PATIENT.DEMOG |
|
| LP410758-9 |
SURVEY.PRAPARE |
|
| LP411304-1 |
PANEL.MOLPATH.PHARMG |
|
| LP411939-4 |
SURVEY.WELLRX |
|
| LP411940-2 |
PANEL.SURVEY.WELLRX |
|
| LP412177-0 |
CLIN.VET |
|
| LP415696-6 |
SURVEY.CSSRS |
|
| LP415697-4 |
PANEL.SURVEY.CSSRS |
|
| LP415703-0 |
Genetics |
|
| LP415704-8 |
InfectiousDisease |
|
| LP415705-5 |
Hematology |
|
| LP415706-3 |
Hepatology |
|
| LP415707-1 |
OT |
|
| LP415708-9 |
ORTHOPEDICS |
|
| LP415709-7 |
ENT |
|
| LP415710-5 |
Rheumatology |
|
| LP417561-0 |
SURVEY.SEEK |
|
| LP418652-6 |
EYE.LENSOMETRY |
|
| LP419121-1 |
PANEL.SURVEY.SEEK |
|
| LP419587-3 |
SURVEY.NIDA |
|
| LP419639-2 |
PANEL.SURVEY.NIDA |
|
